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A COMPARATIVE STUDY OF VARIOUS PROGNOSTICS SCORING SYSTEM (RANSON, BISAP, CTSI) IN 
ACUTE PANCREATITIS  
ABSTRACT 
Acute pancreatitis is a sudden inflammation of the pancreas due to many 
causes. There are many prognostic scoring systems to predict the severity and the 
outcome of the disease. The aim of the study is to compare the three scoring 
system namely RANSON, BISAP and CTSI  in predicting the outcome  such as 
acute severe pancreatitis, pancreatic necrosis, mortality and number of days stayed 
in hospital are considered in the study and to classify the pancreatitis according to 
atlanda classification and study its prognostic significance. 
 METHODS: 
   Extensive  data from consecutive patients with AP admitted o to our 
Coimbatore Medical college was collected between September 2011 and 
November 2012. The BISAP scores were calculated using data from the first 24h 
from admission and the RANSON score within 48 h from admission. Predictive 
accuracy of the scoring systems was measured by the area under the receiver-
operating curve (AUC). 
RESULTS: 
There were 117 patients with AP (mean age 39+/-11). Incidence in males 94%. 
21% patients developed organ failure and were classified as severe AP . 
14%developed, and 7 died (mortality 5.9%). AUCs for BISAP in predicting SAP is 
0.773 and predicting the mortality is 0.789. The AUC FOR CTSI on predicting the 
pancreatic necrosis is 0.814. 
 
 
CONCLUSION 
To conclude BISAP score is simple and it is the better scoring system in 
predicting the prognosis when compared to other score. The BISAP score has 
many advantages when compared to other scoring system. The CTSI score 
predicted the pancreatic necrosis well. Atlanta classification also holds good for 
the classify the pancreatitis into mild and severe disease also holds good to assess 
the prognosis of the acute pancreatitis. 
KEY WORDS: acute pancreatitis, RANSON, CTSI, BISAP.  
 
 
INTRODUCTION
Acute pancreatitis is a sudden inflammation of the pancreas due to many 
causes. The disease can range from mild to severe disease. More often mild 
disease can be treated with conservative management like nil by mouth and the 
pain which is severe, is managed. But severe case is bound to have many 
complications and they need a careful monitoring. We need to know the 
prognosis of the patients with severe disease so complications can be 
anticipated and patients who need monitoring can be found out. 
 There are many prognostic scoring systems to predict the severity and 
the outcome of the disease. In this study three scoring system namely 
RANSON, BISAP and CTSI are compared in predicting the outcome of acute 
pancreatitis. The outcome such as acute severe pancreatitis, pancreatic necrosis, 
mortality and number of days stayed in hospital are considered in the study. 
Then the scoring system are compared in predicting the mortality, pancreatic 
necrosis, acute severe pancreatitis. 
CONCLUSION 
To conclude BISAP score is simple and it is the better scoring system in 
predicting the prognosis when compared to other score. The BISAP score has 
many advantages when compared to other scoring system. The CTSI score 
predicted the pancreatic necrosis well. Atlanta classification also holds good for 
the classify the pancreatitis into mild and severe disease also holds good to assess 
the prognosis of the acute pancreatitis. 
KEY WORDS: acute pancreatitis, RANSON, CTSI, BISAP.  
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AIMS OF THE STUDY
 1) TO COMPARE THE SENSITIVITY, SPECIFICITY, POSITIVE 
AND NEGATIVE PREDICTIVE VALUE OF VARIOUS SCORING  
SYSTEM NAMELY RANSON SCORE, CTSI, BISAP IN PREDICTING 
THE SEVERE ACUTE PANCREATITIS, PANCREATIC NECROSIS, 
MORTALITY AND TO SUGGEST THE BEST SCORING SYSTEM 
AMONG THE THREE PROGNOSTIC INDICATER APPLICABLE TO 
OUR POPULATION 
    2) TO CLASSIFY THE PANCREATITIS ACCORDING TO 
ATLANDA CLASSIFICATION AND TO STUDY ITS PROGNOSTIC 
IMPORTANCE. 
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REVIEW OF LITERATURE
HISTORICAL REVIEW 
• In  Greek Pan means "All" and Kreas means  "Flesh"  and  it was 
described  first by Herophilus Chalcedon. 
• Rufees and Ephesees-named the pancreas. 
• Wirsung- described the main pancreatic duct. 
• Santorini- illustrated the accessory duct bearing his name. 
• Ringor de Graaf- the first reference to pancreatic lithiasis in 1664. 
• Reiddle- chronic pancreatitis was first described by him. 
• Kini- reported the first case of pancreatic calculi In India. 
• Elizabeth and Stephen- reported 9 cases of pancreatic calculi from 
vellore. 
• Chuttani and Anand- reported 32 cases of pancreatits from North India 
with gall bladder disease in 25% of cases and alcoholism in 6%. 
• Brocks and Gifferd- performed the first human homotrans plant in 1959, 
using fragmented pancreatic tissue. 
• Lillehei and colleagues- performed the first human pancreatic whole 
organ transplant in 1967. 
• Ballinger and Lacy- popularised the concept of islet cell transplantation in 
1972.  
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ANATOMY OF THE PANCREAS1,2
Pancreas is a retroperitoneal organ and it lies behind the stomach, 
transverse colon, and mesocolon. The whole, organ measures over 15 cm long 
weighs about 90 to 120 g in adult, soft in consistency with lobulated surface. It 
occupies the supracolic and partly the infracolic compartment. It comprises of 
head, neck, body and tail. 
Head: 
It is the broadest part, occupies the concavity of the duodenum, and lies 
over the inferior venacava, right and left renal veins. Its posterior surface is 
indented by last part of common bile duct. The uncinate process is the wedge 
shaped lower part of the gland, lies posterior to the superior mesenteric artery 
and vein and lies anterior to the aorta, at the level of L2. 
Neck: 
It is the continuation of the upper part of the head, lies anterior to the 
superior mesenteric vein and portal vein formation. It lies at the level of LI 
vertebra. 
14 
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Body: 
The body starts from the neck and it runs across the left renal vein, left 
crus of the diaphragm, aorta, left psoas muscle, hilum or the left kidney and the 
lower pole of the left suprarenal gland. The Splenic artery passes along the 
upper border of the body and tail and it is tortuous in course. Splenic vein lies 
closely applied to its posterior surface. The Splenic vein gets its tributary from 
the inferior mesenteric vein behind the body of the pancreas. The transverse 
mesocolon is attached in the lower part of the anterior surface of the body and 
neck. 
Tail: 
It passes forwards from the anterior surface of the left kidney at the level 
of hilum, accompanied by splenic artery, splenic vein and lymphatic in the two 
layer of lieno renal ligament and then touches the hilum of the spleen. 
Ductal system of pancreas: 
The duct of Wirsung is the major duct comes from the tail to the head, 
arises from the confluence of numerous small ducts of the lobules crossing the 
gland forming a "Herring bone" pattern, gradually increasing in diameters upto 
10 mm joins with the common bile duct in a dilatation, the ampulla of vater, 
which opens into the duodenal papilla. The accessory pancreatic duct drains the 
uncinate process and lower part of the head of pancreas lies more on ventral 
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plan, opens into the duodenum 2 cm proximal to the major papilla and 7 cm 
distal to the pylorus ". Injury to the duct of Santorini in the pancreatic divisum 
during gastrectomy results in severe hemorrhagic or recurrent pancreatitis. 
Blood supply: 
Blood supply is chiefly derived from splenic artery which supplies neck, 
body and tail by a large branch named as "arteria pancreatica magna". The head 
is supplied by superior pancreatico duodenal artery (a branch of coeliac artery) 
and inferior pancreatico duodenal artery (a branch of superior mesenteric 
artery). The right hepatic artery is a branch of superior mesenteric artery, passes 
behind the head of the pancreas or within its substance. 
Venous drainage is by small veins into the splenic vein and the head of 
the pancreas drain into the superior pancreatico duodenal vein into the superior 
mesenteric vein which forms a landmark during pancreatic resection. 
Lymphatic drainage: 
Lymphatic drainage generally follows venous drainage in all directions. 
They drain into the following group of lymph nodes 
A. Superior nodes drain the anterior and superior upper half of the gland. 
B. Inferior nodes drain the anterior and posterior lower half. 
C. Anterior nodes drain the anterior surface of the head of the pancreas. 
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D. Posterior nodes drain the posterior surface of the head. 
E. Splenic nodes drain the tail of the pancreas. 
Every group of lymph node finally drains into the coeliac and superior 
mesenteric group lymph nodes. 
Nerve supply: 
The afferent pain sensation from the pancreas is conducted through the 
sympathetic fibers from the greater, lesser and lowest splanchnic nerves via the 
central ganglia. The coeliac branch of the right vagus nerve provides the 
parasympathetic supply. 
Development of pancreas: 
The   Pancreas develops as two separate buds each an outgrowth of the 
endoderm at the junction of foregut and midget. The ventral bud grows 
into the ventral mesogastrium in common with the outgrowth of bile duct 
and the dorsal bud grows into the dorsal mesogastrium. The duodenal portion of 
the duct rotates and becomes adherent to the posterior abdominal wall, the 
ventral bud rotates and fuses with the dorsal bud at 7 to 8 weeks of gestation. 
The dorsal pancreatic duct by connecting with the ventral pancreatic duct 
becomes the major duct of Wirsung draining the body and tail, the proximal 
end is retained as accessory pancreatic duct of Santorini. This duct opens into 
the duodenum separately in 70 % of cases and in 5 % of cases it becomes the 
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major duct - pancreatic divisum. 
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The pancreatic alveoli developed by the growth of cells from the terminal 
part of the branching ducts. The islet cells appear to have as identical origin but 
become separated from their parent ducts and undergo change of secretary 
function. 
Microscopic anatomy: 
This lobulated gland composed of alveoli of serous cells with, very few 
ducts without islet cells by characteristic staining reaction. In each alveolus the 
basal part of the cell is deeply stained and basophilic, while the central part is 
acidophilic. The nucleus is situated towards the basal part. The ducts are lined 
with simple columnar epithelium. 
The islets, in section appear as pale areas, more prevalent in the tail with 
Zankes - formal fixation. It varies in size from one to four times that of 
pancreatic alveolus. Alpha cells produce glucagon which is situated more in the 
periphery of the islets, constitutes 18 to 25% of the cells. Beta cells producing 
insulin has secretory granules, density of which varies in patient to patient. The  
Delta cells producing somatostatin constitutes 3 to 8 % located near the alpha 
cells contains granules demonstrated by Electron Microscopy. 
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PHYSIOLOGY18,4
The pancreas has both the endocrine and exocrine functions. 
Exocrine pancreas - The acinar cells of the pancreas secrete enzymes and 
small amount of electrolytes. The centroacinar and ductular cells secrete 
water and electrolytes. 
Composition - Total volume - 1500 to 2000 ml/day      
                        Protein - 5to8 G pH - alkaline (8.3) 
It is isoosmotic and alkalinity is due to the bicarbonate 
concentration which depends on the secretory rate (100 to 150 mmol/1). 
The Na+ and K+ concentration is similar to the plasma but other anions 
and chlorides are inversely related to the bicarbonate concentration and 
are flow dependant. 
Proteins in pancreatic juice: 
 1. Amylolytic enzymes -alpha amylase 
  2. Proteolytic enzymes 
a)Endopeptidases-Chymotrypsinogen,Trypsinogen,Proelastases 
b)Exopeptidases- Procarboxypeptidase 
3. lipolytic enzymes  -  lipase 
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4. Other enzymes – Phospholipase A, carbonyl ester hydrolase,  
     Ribonuclease Deoxyribonuclease 
5. Other proteins-Immuno globulins, Lactoferrin, CEA 
REGULATION OF SECRETION
Both nervous and hormonal control. 
I. Cephalic Phase 
Stimuli similar to gastric secretion. 
Efferent fibres - Vagus nerve 
Volume of secretion - small 
 Enzyme - High 
Hormone - Gastrin from antrum. 
II. Gastric Phase 
Secretion further stimulated. 
Both nervous and humoral control 
Distension of body of stomach excite tension in the wall Vasovagal 
reflex and causes increased enzyme output Gastrin release due to 
chemical or mechanical stimuli which produces enzyme rich sma11 
volume secretion. 
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III. Intestinal Phase 
Acid chyme enters the duodenum and causes the release of 
hormone secretin from the endocrine cells of the mucosa. Secretin 
stimulates watery secretion and an isoosmotic solution of bicarbonates. 
Pancreozymin hormone from the I cells in crypts and villi of 
duodenum and jejunum on release stimulates enzyme rich secretions.
ACUTE PANCREATITIS
Defined as pancreatic inflammation followed by clinical and 
biological restitution gland if the primary cause is eliminated. Different 
stages are distinguished in the development of acute pancreatitis. There 
are a number of known and unknown etiologic factors capable of 
initiating pancreatic inflammation in a variety of ways that finally results 
in pancreatic necrosis 
Pancreatic involvement may be confined to the initial damage and 
may cease spontaneously or gives rise to an activation of digestive 
enzymes within the pancreas thereby self perpetuating pancreatic auto 
digestion with fat necrosis and hemorrhage. 
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ETIOLOGIC FACTORS2
A number of factors either acting alone or a combination of them 
may be responsible for the pancreatic onslaught, Etiological factors in 
acute pancreatitis 
I. METOB0LIC 
• A1cohol 
• Hyper1ipoprotenemia 
• Hypercalcemia  
• Drugs 
• Scorpion venom  
II MECHANICAL 
• Choielithiasis 
• Post, operative [gastric, biliary]  
• Post traumatic  
• Obstruction of the duct  
• Pancreatic tumor 
• Duodual obstruction 
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III VASCULAR 
• Post operative (cardio pulmonary bypass)  
• Periarteitis nodosa  
• Atheroembolism 
IV INFECTIONS 
• Mumps  
• Coxsackies  Infection  
 
DEVELOPMENT OF ACUTE PANCREATITIS4,5
Etiological factor described above initiate the process of bile reflux 
and causes the pancreatic injury. The pancreatic injury is manifested as 
edema, vascular injury, and pancreatic acinar damage. This injury causes 
the activation of the pancreatic enzymes such as trypsin, phospholipase A 
etc. This leads to autodigestion and pancreatic necrosis. 
MECHANISM BY WHICH COMMEN ETIOLOGICAL FACTOR CAUSES ACUTE 
PANCREATITIS 
A) ALCOHOL - MECHANISM OF INJURY 
• Panacreatic exocrine hypersecretion in the presence of partial 
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ampullary obstruction. 
1. Alcohol is a stimulant of gastric acid sceretion, and the 
resultant duodenal acidification relases secretin which 
increases the exocrine pancreatic secretion of water and 
bicarbonate 
2. Alcohol also increases the resistance of sphincter of Oddi 
causing partial obstruction to the flow of pancreatic secret ion. 
3.  Alcohol increases the intraductal pressure in pancreatic ducts 
and also increases permeability of ducts to macromolecules. 
• Alcohol initiates enzyme extravasation and cause pancreatic 
injury as a result of protein obstruction of the pancreatic duct. 
• Intermediate state of hypertriglyceredemie following alcohol ingestion. 
Toxic levels of free fatty acids, produced from the lipolysis of 
triglycerides may cause acinar cell or capillary endothelial cell injury in 
the pancreas. 
B) GALL STONES 
Mechanism 
Gall stone migration through the ampulla of Vater, causes 
diversion of bile into the pancreatic duct and subsequent bile-induced 
pancreatic parenchymal injury. 
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Evidences 
• Presence of Gall stones in stools of 90% of patients with 
acute Gall stone pancreatitis. 
• Cholangiographic studies show a common channel 
between the CBD and pancreatic duct in 90% of patients with Gallstone 
pancreatitis. 
• Intraoperative cholangiogram after cholecystectomy 
shows that pancreatic duct reflux in 60% of patients with history of 
pancreatitis. 
• Endoscopic recovery of stones impacted at Ampulle of 
Vater within 48hrs of onset of symptoms. 
C) HYPERLIPOPROTENEMIA 
D)  Pancreatitis associated with various primary hyperlipoprotenemic 
conditions are as follows. 
Disease % occurance of pancreatitis 
Fredrickson Type I 30% 
Type IV 15% 
Type V 27 - 41% 
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Since Type IV is the commonest form of Hyperlipoprotenemia, 
this accounts for mo6t examples of lipid associated pancreatitis. Free 
fatty acids released by pancreatic lipase may exert a toxic influence as 
the pancreatic parenchyma. 
E) HYPERPARATHYROIDISM AND HYPERCALCEMIA 
Incidence-7 -19%  
Mechanism 
• Calcium induced trypsinogen activation and subsequent 
auto destruction. 
• Calcium associated stone precipitation in the duct 
causing obstruction. 
• Calcium stimulated pancreatic exocrine hypersecretion. 
Direct toxic effect on parenchyma of pancreas by paratharmone. 
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MECHANISM OF ACUTE PANCREATITIS4,5
I. INTRA PANCREATIC ACTIVATION OF PANCREATIC 
ZYMOGENS 
The cardinal mechanism is the activation of the trypinogen to 
trypsin and this enzyme activates the other enzymes and the pathology 
continues. Whatever may be the etiology finally it lands upon the above 
given mechanism. 
A concept known as the intrapancreatic activation of the enzymes 
in postulated. The release of the pancreatic enzyme is hindered and they 
join the intracellular lysosomes and this results in the activation of the 
proenzyme trypinogen to trypsin. This results in activating all known 
pancreatic zymogens like chymotrypsinogen to active chymotrypsin, 
proelastase to elastase and prophospholipase to lipase A. Only lipase 
already synthesized in active form is independent of trypsin. Every 
activated enzyme has its own function and it is summarized in the flow 
chart. 
 Of the all etiological factor alcohol is the most common cause of 
the acute pancreatitis so its mechanism is discussed. The mechanism is as 
follows. 
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• Hyper secretion of the exocrine pancreatic secretion in the 
presence of the partial ampullary obstruction. 
• Enzyme extravasations initiating the pancreatic injury 
• Alcoholic usually have hypertrigiyceredemia this also initiates 
the pancreatitis. 
 The next common cause in the gallstone pancreatitis. Gall stone 
migrates into the ampulla of vater which causes the diversion of the bile 
into the pancreatic duct which results in the bile induced pancreatic 
injury. 
PATHOLOGICAL CHANGES ACUTE PANCREATITIS5
Mildest pathological change - Edema of the gland. May be 
accompanied by infiltration of the intralobular septa by inflammatory 
cells. 
Microscopy-fat necrosis in the pancreas and surrounding tissues. 
If extensive necrosis - Whitish yellow plaques occur due to necrosis 
and calcium deposition. 
Vascular thrombosis or disruption results in pancreatic necrosis or 
gross hemorrhagic infarction. 
Increased levels of active pancreatic enzymes occur, 
1. within pancreas 
2. in the peritoneal exudate 
3. in the blood stream of patients with pancreatitis 
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FIG 4 ACUTE PANCREATITIS SPECIMEN
The specimen shows acute pancreatitis with severe necrosis  
31 
32 
CHANGES IN DIFFRENT SYSTEM IN PANCREATITIS
The pathophysiology alters many system in the body. The changes 
affects the following system. 
• Fluid and electrolyte changes 
• Cardiovascular changes 
• Respiratory changes 
• Renal changes 
• Local changes 
I. FLUID AND ELECTROLYTE CHANGES 
Circulating blood volume decreased due to loss from 
intravascular space of plasma into the retroperitoneum and systemically. 
Additional loss occur following vomiting or naso gastric aspiration. 
Hypocalcaemia and hypomagnesemia are frequent. Decreased ionised 
calcium level also occurs due to trapping of calcium in areas of fat 
necrosis. 
II. CARDIOVASCULAR CHANGES 
Hypotension, Tachycardia, increased total perpheral resistance and 
decreased cardiac output - sequelae of hypovolemia also observed in 
acute pancreatitis similar to septic shock or Hepatic cirrhosis are due to 
circulatory vasoactive substances. Hypotension persists despite 
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restoration of intravascular volume. 
III. RESPIRATORY COMPLICATIONS 
• Early feature of acute pancreatitis -arterial hypoxemia 
• Pulmonary function studies - Decreased inspiratory lung volume 
with decreased pulmonary compliance and decreased diffusing 
capacity. 
• Early respiratory failure resolves with subsidence of pancreatitis. 
• Severe or unresolving pancreatitis may develop progressive 
pulmonary insufficiency, infiltrates and pleural effusion. 
IV. FACTOR IMPLICATED FOR PULMONARY 
COMPLICATIONS 
1. Abdominal distension and elevation of diaphragm. 
2. Alteration in the lecithin of pulmonary surfactant by 
circulating pancreatic lecithinase. 
3. Pulmonary thromboembolism. 
4. Circulating free fatty acids 
5. Circulating products of the proteolytic cleavge complement. 
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V. RENAL FAILURE 
Major factor is deaths from pancreatitis. Due principally to 
hypovolemic. So many patients go in for acute renal failure. 
Pathologically it is due to the deposition of the fibrin complexes in the 
glomeruli.  
VI. OTHER SYSTEMIC FEATURES 
Abnormal Liver functions-Elevation of serum bilirubin and liver 
enzymes such as Alkaline Phosphatase are raised and it is mainly due 
to the biliary obstruction and pericholangitis.  
Early Intravascular thrombosis  with decreased platelet count 
and fibrinogen level occur due to the effects of pancreatic proleolytic 
enzymes. May be followed by marked thrombocytosis and 
hyperfibrinogenemia. 
VII. LOCAL SEQULAE 
Intra abdominal complications 
1) Paralytic ileus 
2) Duodenal/Biliary obstruction 
3) Release of pancreatic enzymes with peripancreatic fluid 
collection and fluid in general peritoneal cavity. 
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4) Destruction of tissues adjacent to pancreas. 
5) Rarely cause gross disruption of the pancreatic ductal system 
which is usually self limited. 
6) Persistent chronic pseudocyst in 1% 
7) Infected pancreatic abscess due to secondary infection occur 
in 1-9% and organisms are usually enteric. 
8) Extension of local necrosis to involve colonic wall causing 
colonic perforation occurs in 1% and occurs in the left 
transverse colon or splenic flexure. 
CLINICAL MANIFESTATIONS AND DIAGNOSIS2,3,10
The classical feature of acute pancreatitis is its severity of 
symptoms and paucity of physical signs. 
1. Abdominal pain - 85 -100%
Upper abdominal constant pain may radiate to the back and-may 
be severe. Pain is aggravated by the food or by a drink of alcohol. Pain 
resistant to analgesics. Patient assumues of various postures in an 
effort to obtain relief. 
2. Nausea and vomiting - 92% 
 Vomiting is usually non projectile and it is of low volume and it 
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contains gastric and duodenal content and it is not feculent. 
3. Physical examination 
• Restless patient. 
• Rapid pulse and respiratory rate. 
• Arterial hypotension 
• Abdomen- moderately distended with epigastric dullness 
Tenderness markedly in the upper abdomen. 
• Moderate muscle spasm present. 
• GREY TURNERS SIGN - Grey green  discoloration of the 
flank in patients with peripancreatic heamorrhage
• CULLEN' S SIGN - bluish discoloration of periumbilical region 
4. Extra abdominal manifestations  
• Left pleural effusion 
• Acute pulmonary failure marked by Tachypnoea, dyspnoea,  
• cyanosis - due to 
a) circulating phospholipase A 
b) circulating free fatty acids from triglycerides from  1ipolysis 
c) Pulmonary surfactant 
d) Volume overload with pulmonary capillary leakage 
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5. Central Nervous System manifestations- 
Nonlateralizing nature, including billigerence, confusion, 
psychosis and coma. This is due to hyperosmolarity, hypoperfusion, 
hypoxia, cerebral fat embolism or Disseminated intra vascular 
coagulation. 
LABORATORY DETERMINATION2,18
DIAGNOSIS OF ACUTE PANCREATITIS
Laboratory Tests   Radiographic Procedures 
• Sr. amylase • Chest X Ray 
• Sr. amylase isoenzymes • Plain abdominal X Ray 
• Urine amylase • Ultrasonography 
• Amylase-creatinine clearance 
ratio 
• Contrast enhanced C T SCAN 
I. BLOOD COUNT  : 
• Leucocytosis  - 10,000 to 20,000 occurs early in all cases 
• Haematocrit - is high in most patients at the onset. 
• Haemoglobin decreased value of more than 2.5G% without  
detectable blood loss found in those with pancreatic necrosis 
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II. SERUM AMYLASE 
Elevated in 95% of patients with Acute pancreatitis. But this is not 
an ideal marker because it is elevated in other conditions such as
A. Perforated peptic ulcer 
B. Biliary lithiasis 
C. Intestinal obstruction 
D. Mesenteric infarction. 
Also in patients with acute pancreatitis, serum amylase in normal 
levels can occur due to 
I. Hyper triglyceredemia - Latescent serum 
II. Assayed 3 days or more after onset 
III. Previous attack has destroyed most glandular tissues 
IV. Present attack is associated with massive destruction of 
gland 
Serum amylase in Acute Pancreatitis is elevated within 24 hrs of 
onset of symptoms and returns to normal in 7 days. 
III. SERUM ISOAMYLASE P: 
As it is produced only from pancreas it has a higher specificity in 
detection and confirmation of acute pancreatitis. 
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IV. SERUM LIPASE: 
Serum lipase is solely of pancreatic origin hence serum lipase 
level is more specific than amylase. Recent development of an enzyme 
immuno assay of lipase is reliable and is of great value in Acute 
Pancreatitis. Duration of Hyper lipasemia exceeds hyperamylossemia. 
V. PLURAL AND PERITONEAL FLUID AMYLASE 
Pleural effusion shows raised levels of amylolytic activity in 
pancreatitis. High activities of amylase may also be found in fluids 
aspirated from peritoneal cavity in patients with acute pancreatitis. 
IV. OTHER BIOCHEMICAL INDICES 
I. Hyperglycemia and Glycoscuia- Nonspecific, transient 
Cause - relative hypoinsulinemia and Hyperglucognaemia 
II. Hypocalcemia - Well recognised entity in acute pancreatitis 
but can also occur in perforated peptic ulcer 
Cause - Deposition of calcium in areas of fat necrosis Release of 
glucagon Inadequate parathyroid response Dilutional hypo albuminaemia 
i. Methemalbumin: 
Appearance in serum indicates necrotic rather than edematous 
pancreatitis. 
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ii. Liver function tests: 
Slight increases in alkaline phosphatase and amino transfer are 
with raise in serum bilirubin - transitions. Markedly elevated serum 
aspartate and alanine amino transfer are within 48 hrs after onset 
discrimianates biliary from non-biliary pancreatitis. 
RADIOGRAPHIC FINDINGS2,18
I PLAIN X-RAYS 
i). Plain X-Ray abdomen 
a) Segmental small bowel ileus or a “SENTINEL LOOP’ in the left 
upper quadrant. 
b) Dilatation of the transverse colon – “COLON CUT OFF SIGN”. 
A. Increase epigastric soft tissue density 
B. Obscured psoas muscle margins. 
C. Presence of gall stones 
D. Pancreatic calcification – may not be an acute pancreatitis
ii). Plain x-ray chest 
(a) Pleural effusion 
(b) Atelectasis 
(c) Pneumonia 
(d) Pulmonary edema 
COLON CUT OFF SIGN
CONTRAST STUDIES WITH WATER SOLUBLE 
CONTRAST 
 Upper Gastrointestinal study 
(a) widening of “C” loop 
(b) Anterior displacement of stomach 
(c) Subtle duodenal mucosal sign 
ABDOMINAL ULTRASONOGRAM 
(a) enlargement and edema of pancreas 
(b) Pseudocysts of pancreas 
(c) Delineates pancreatic abscess 
(d) Dilatation of Bile duct and presence of stone in gall bladder  
 and common vile duct 
COMPUTED TOMOGRAPHY 
Except in early or mild eases it is useful in assessing Ct scan 
reveals many finding in the pancreatitis. Pancreas is usually enlarged and 
there is pancreatic edema. Pancreatic necrosis is characterized by the non 
enhancement in the contrast Ct scan. In the peri pancreatic area there  is 
collection, obliteration of the fat plane and thickening of the fat plane. 
Other finding are ileus, pleural effusion. 
VI ENDOSCOPY 
To detect biliary pancreatitis. 
Therapeutically used for papillotomy and removal of stones 
impacted at the ampulla of Vater. 
TREATMENT3,10
MEDICAL MANAGEMENT
A. NUTRITION 
1. Enteral nutrition 
Previously it was thought that enteral nutrition stimulates the 
pancreas and results in pain in pancreatitis, but now it is found that 
pancreas is actually in a state of rest in acute pancreatitis so it better to 
stimulate the pancreas. So enternal feeding does no harm to the patient. 
2. Total parenteral nutrition 
TPN is associated with many complications such as arterial injury, 
pneumothorax, thrombosis, and catheter embolism. Many studies comfirm that 
enternal nutrition is better than TPN. 
B. GASTRITIS  PREVENTION 
Patients suffering from severe AP have risk to develop peptic ulcers 
or erosive gastritis Histamin2-antagonists IS indicated in patient on 
mechanical ventilation and patients with adult respiratory distress syndrome 
(ARDS) 
C. FLUID MANAGEMENT 
Adequate fluid management is the main stay in the management of acute 
pancreatitis. If missed it can lead to serious complications. Plenty of fluids are 
sequestrated in third spaces. So crystalloids and colloids are used in the ratio of 
3:1. The fluid loss may be 6-10 liters. It is said that when hematocrit is less than 
30% if Dextran is used it improves the microcirculation. Good fluid resuscitation is 
indicated by adequate urine out put, CVP AROUND 8-12 cm of water, hematocrit 
of 35-40%. 
D. PAIN MANAGEMENT 
As a result of the activation of pancreatic enzymes there are increase 
releases of the inflammatory mediators. These mediators irritate the sensory fibers 
of the celiac plexus (T5-T9) and cause severe pain radiating to the back. The 
following drugs are used in management of pain 
• nonsteroidal analgesia 
• meperidine 
• Tramadol 
• thoracic epidural analgesia
E. THE ROLE OF ANTIBIOTICS9 
There is a great controversy regarding use of antibiotic in acute pancreatitis. 
Since there is great risk in developing necrosis in acute pancreatitis, there is also 
problem in developing abscess in acute pancreatitis. So in order to prevent the 
abscess formation antibiotics are used. The most common antibiotics used are 
imipenem, meropenem, metronidazole, fluoroquinolones, and cephalosporins. 
These antibiotics penetrate the pancreas well, but aminoglycosids do not penetrate 
the pancreas. Over use of antibiotics result in the fungal infection.  
F. SUPPRESSION OF PANCREATIC EXOCRINE SECRETION 
These are done by nasogastric suction, histamine H2-receptor antagonists, 
antacids,atropine, glucagon, calcitonin, stomatostatin. 
SURGICAL MANAGEMENT: INDICATIONS AND TIMING
INDICATIONS14,19,23
1. Uncertainity of diagnosis 
2. Treatment of pancreatic sepsis 
3. Correction of associated biliary tract disease 
4.     Progressive clinical deterioration despite optimal   
supportive care. 
5.     Infected necrosis 
6.     Severe sterile necrosis 
7.     Symptomatic organized pancreatic necrosis 
A) BILIARY OPERATIONS IN PATIENTS WITH CHOLELITHIASIS
a. Cholecystostomy 
b. Common duct drainage 
c. Cholecystectomy 
d. Early endoscopic papillotomy 
In patients with severe gall stone pancreatitis early intraabdominal 
surgery has been associated with higher mortality than early non operative 
treatment. Surgical correction of cholelithiasis to prevent recurrent 
pancreatitis undertaken once evidence of pancreattitis has subsided usually 
during the same hospital admission. 
B) SURGICAL MANAGEMENT: PROCEDURES19,23
1. RESECTION 
2. PANCREATIC DEBRIDEMENT 
3. MINIMALLY INVASIVE APPROACHES 
• Retroperitoneal approach via dorsal lumbotomy 
• Percutaneous necrosectomy and sinus tract endoscopy 
RESECTION 
Pancreatic resection is primarily of historical interest only and is not 
recommended currently 
PANCREATIC  DEBRIDEMENT 
All pancreatic débridement and postdébridement care are based on : 
(1) Wide removal of devitalized and necrotic tissue  
(2) the assurance of postoperative removal of the products of ongoing 
local inflammation and infection  
TECHNIQUES OF DÉBRIDEMENT 
1. Débridement and closed drainage 
2. Open packing for pancreatic necrosis 
3. Débridement And Continuous Closed Postoperative Lavage Of The Lesser 
Sac 
THE COMPLICATIONS OF ACUTE PANCREATITIS2,18
The Complications of Acute Pancreatitis 
Local Fluid collections 
Pancreatic ascites/pleural effusion 
Pancreatic pseudocyst 
Pancreatic necrosis 
Infected pancreatic abscess 
Hemorrhage/pseudoaneurysm 
Regional Venous thrombosis 
Paralytic ileus 
Intestinal obstruction 
Intestinal ischemia/necrosis 
Cholestasis 
Systemic Systemic inflammatory response syndrome 
Multiple-organ-dysfunction syndrome 
ARDS/pulmonary failure 
Renal failure 
Cardiovascular complications 
Hypocalcemia 
Hyperglycemia 
Disseminated intravascular coagulopathy 
Protein calorie malnutrition 
A) PANCREATIC ABSCESS 
Pancreatic abscess - Incidence '9%. Most common in patients with 
post operative pancreatitis. 
Clinical features 
Persistent of recurrent fever 
Abdominal distension 
Abdominal mass 
Hypotension (BP 9 0 mmHg). 
Pneumonia / Effusion 
Renal failure 
Coma 
Elevated serum amylase 
Leucocytosis ( 10000 /mm^) 
Radio graphic diagnosis 
1. Upper GI contrast studies showing di splacement of 
stomach or duodenum. Gas outside :GIT,. 
2. Ultra sound abdomen can delineate pancreatic abscess 
3. Computed Tomography sensitive and specif.lc 
4. Percutaneous aspiration under CT guidance 
Treatment 
Adjuvant 
1. Vigorous supportive management 
2. Meticulous respiratory care nutritional support 
3. Prevention of GIT haemorrhage 
Specific 
1. Percutaneous drainage by catheter 
2. Laprotomy - Debridement and packing of the pancreatic bed. 
3. Surgical correction of other complications like 
involvement of colon by colostomy 
4 Feeding jejunostomy  to correct nutritiona1 imbalance 
B) PSEUDOCYSTS 
 Pseudocysts following acute pancreatitis spontaneous 
diSAPpearance of pseudocysts is a common occurence in acute pancreatitis. 
These are carefully monitored by serial ultrasonogram or CT and operative 
intervention is needed only when they go in for further complications. It is 
dealt in detail along with treatment for pseudocysts following chronic 
pancreatitis. 
C)PANCREATIC ASCITES
 Pancreatic ascites - more common following chronic pancreatitis. But 
may also follow acute pancreatitis secondary to trauma, pseudocysts and 
rarely pancreatic neoplasm.Treatment is by drainage procedures as dealt in 
pancreatic ascites following chronic pancreatitis. 
PROGNOSTIC ASSESSMENT 
PROGNOSTIC INDICATORS  
Because of the variability and unpredictability of acute pancreatitis, 
clinical scoring systems have been made to predict the severity of acute 
pancreatitis  
1 . RANSON S CRITERIA6
RANSON criteria is the most commonly used scoring system and is based 
on 11 parameters measured within the first 48 hours of admission to the hospital 
.It is detailed  in the tabular column 
RANSON's Criteria
RANSON's Criteria 
Nonbiliary Acute 
Pancreatitis 
Biliary Acute 
Pancreatitis 
Admission
Age (yr) >55 >70 
WBC count (×1000/mm3) >16 >18 
Glucose (mg/dl) >200 >220 
AST (IU/L) >250 >250 
LDH (IU/L) >350 >400 
Within 48 Hours of Admission
Hematocrit decrease 
(points) 
>10 >10 
BUN increase (mg/dl) >5 >2 
Deficit in base(mEq/L) >4 >5 
Fluid replaced (L) >6 >4 
PaO2 (mm Hg) <60 <60 
Calcium (mg/dl) <8 <8 
To calculate base deficit first bicarb VD must be calculated 
Bicarb Vd =(0.4+2.6/HCO3) x Lean Body Weight 
Base Deficit= Bicarb Vd x (Normal HCO3- Measured HCO3)  
RANSON's score interpretation 
According to RANSON score when the score is > 8 it indicates pancreatic 
necrosis upto 30% of the gland. If the score is >= to three the severe pancreatitis is 
likely and if it is < than three the severity is unlikely. 
Score 0 to 2: The mortality is 2% 
Score 3 to 4: The mortality is 17% 
Score 5 to 6: The mortality is 45% 
Score 7 to 8: The mortality is nears 100% 
In this study the cut of value of the score is 3.the patients are classified under 
two groups one with RANSON score < 3 another with score >=3 since a score less 
than three severe pancreatitis is unlikely. 
2. BISAP SCORE13
The BISAP is the simplest score in identifying the patients with rule of 
mortality and severity in 24hrs period calculation of risk can improve the clinical 
care. The score was developed in state of pennyyslvania using a huge cardinal 
health database. 
INDIVIDUAL COMPONENTS OF THE BISAP SCORING SYSTEM
• Impaired conscious level (GCSS < 15) 
• Blood urea level > 25mg/dl 
• Age > 60 
• Pleural effusion 
• Systemic inflammatory response syndrome 
 The syndrome contains two or more of the following : 
  (1) Temperature of < 36 or > 38 ° C 
(2) Respiratory rate > 20 breaths/min or P a CO2 < 32 mm Hg 
(3) Pulse > 90 beats/min 
(4) WBC < 4,000 or >12,000 cells/mm 3 or >10% immature bands 
The total score is 5. In this study the cut of value of the score is 3, the patient 
are classified into two group one group with score < 3 and the other group with 
score >= 3. 
3)  CT SEVERITY INDEX2
 This uses CT scan primarily to grade the severity. CT scan is used to find the 
pancreatic changes and necrosis. Either contrast or plain ct is used. This is developed by 
BALTHAZAR and AP is graded from A to E. It gives point according to the following 
criteria, 
1. Nature of necrosis  
   2. peri pancreatic changes  
ACUTE PANCREATITIS WITH EDEMA
SEVERE NECROTIC PANCREATITIS
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Mild pancreatitis, interstitial pancreatitis
Patients with pancreatitis having no collections or necrosis. They have a mild 
pancreatitis.  Balthazar grade A-C come under this group. CTSI is 2 
Severe pancreatitis or necrotizing pancreatitis 
   They occur in 20 of patients. They have uneven clinical course and high mortality 
rate. They are more than fluid collections. The grade is d or e and this score is usually 
above 3. The peripancreatic collection is due to fat necrosis. This group of patients with. 
Necrosis has most complication and they have to be identified. There is a separate type 
called extra pancreatic necrosis which has on pancreatic necrosis the CTSI is 4. 
Balthazar Scoring for the Grading of Acute Pancreatitis 
Grade A – normal CT 
Grade B – focal or diffuse enlargement of the pancreas 
Grade C – pancreatic gland abnormalities and peripancreatic inflammation 
Grade D – fluid collection in a single location 
Grade E – two or more collections and/or gas bubbles in or adjacent to pancreas 
CT severity index = CT grade point + points for necrosis 
 First grade points are calculated. The grade A, B, C, D, E have 0, 1, 2, 
3, 4 respectively. The points for necrosis are based on the percentage of 
necrosis. When the necrosis is <30% the point is 2, 30-50% the point is 4,>50% 
the point is 6.  
CT grade points are added to points assigned for percentage of necrosis to 
determine the CT severity index. So the patients with score greater than three is 
said to manifest severe disease. So in this study two category one with score < 3 
and another with score > =3 are taken into consideration 
OTHER PROGNOSISTIC SYSTEMS
• The Acute Physiology and Chronic Health Evaluation II (APACHE II) 
score. 
• C-reactive protein (CRP) assays. 
• Trypsinogen-activating peptide (TAP) assays.
ATLANDA CLASSIFICATION
1) ACUTE ODEMATOUS PANCREATITIS – MILDER FORM 
MORTALITY 1% 
2) ACUTE NECROTISING PANCREATITIS – incidence of 20% and 
characterized by pancreatic necrosis. The mortality is 15-20%. 
MATERIALS AND METHOD
STUDY AREA :
GOVT. COIMBATORE MEDICAL COLLEGE AND HOSPITAL 
STUDY POPULATION :
Patients admitted in CMCH with symptoms suggestive of acute 
pancreatitis 
INCLUSION CRITERIA :      
1. Clinical findings suggestive of abdominal pain characteristic of acute 
pancreatitis, serum amylase raised 3 times above normal value, ct scan 
with finding suggestive of acute pancreatitis data from the patient 
admitted with acute pancreatitis was collated. When some values are 
missed the referred case no mark is given. The data for RANSON is 
collected for 24 hrs and 48 hrs. CT scan is taken within 48 hrs. BISAP 
is calculated with 24 hrs data. 
The Following criteria are studied  
1. Severe pancreatitis    2. Pancreatic necrosis 
     3. Morbidity     4. Mortality 
DEFINITION
1. MILD OR SEVERE AP  
Depending on the organ failure the patients are classified into mild or 
severe pancreatitis. The presence of organ failure is again dictated by the 
presence of following factor 
• Pulmonary failure(pco2 < 60mm of hg) 
• Renal failure(serum creatinine levels > 2 mg/dl) 
• Severe shock  
2. PANCREATIC NECROSIS 
This finding is easily found by the CECT scan. This is detected by the no 
enhancement in the CECT scan in the pancreatic parenchyma. 
3. MORBIDITITY 
Length of the hospital is used as the indicator of the morbidity 
EXCLUSION CRITERIA :
      1. Pediatric patients were excluded from the study. 
      2. Pregnant and postpartum patients were excluded 
STUDY PERIOD:
 September 2011, November 2012. 
SAMPLE SIZE:
All patients eligible by inclusion and exclusion criteria are to be included 
in the study. 
STUDY DESIGN:
A cross sectional observational study 
RESULTS
STATISTICAL ANALYSIS:
The data are reported as the mean +/- SD or the median, depending on 
their distribution. The differences in quantitative variables between groups were 
assessed by means of the Unpaired t test. Comparison between groups was 
made by the Non parametric Mann - Whitney test. The chi square test was used 
assess differences in categorical variables between groups. Data were analyzed 
by diagnostic efficiency derived from the receiver operating characteristic 
[ROC] Curve and area under the ROC curve. Sensitivity, specificity and 
predictive values were determined. A p value of <0.05 using a two-tailed test 
was taken as being of significance for all statistical tests. All data were analyzed 
with a statistical software package. (SPSS, version 16.0 for windows) 
After calculating the sensitivity, specificity, PPV, NPV for the scoring 
system such as RANSON, BISAP,CTSI in predicting the mortality, pancreatic 
necrosis, acute severe pancreatitis, the results are compared to derive at the 
conclusion. 
The results are summarized with the explanation below 
A) AGE SEX DISTRIBUTION
Table 1 – Age Sex Distribution
Age Male Female Total 
<= 30 23 1 24 
31 - 40 37 2 39 
41 - 50 35 4 39 
51 - 60 8 0 8 
 >= 60 7 0 7 
Total 110 7 117 
The above tabular column 1 gives the age sex distribution of the disease 
in the various age group. 
Table 2 – Mean SD for Age
Sex N Mean +/- SD Range 
Male 110 39 +/- 12 16 - 72 
Female 7 39 +/- 9 23 - 50 
Total 117 39 +/- 11 16 - 72 
 The above tabular column gives the mean and the SD for the age. The 
explanation is as follows. 
The total patients studied in this study were 117, which comprises of 110 
males and 7 females. Among the male population the maximum age group is 
31-40. Next comes the 41-50 which includes 35 patients. Among the female 
population the maximum age group is 41-50 which includes about 4 patients. 
The next tabular column 2 clearly shows the mean and the standard 
deviation of the age group. On the whole it is 39+/-11. It is 39+/- 12 for male 
and 39+/-9 for female. The bar diagram shows the same in the percentage. 
Males greater than 60 years of age affected by the disease are 6%. This is the 
least age group affected.    
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Sex distribution is shown in the pie chart. 6 percent is female and 
the rest is males. In our population males are commonly affected than 
the female population. This factor has link with the etiology, in our 
population alcohol is the common cause of the acute pancreatitis.  
Alcohol consumption is not prevalent in female population so female 
are not commonly affected by acute pancreatitis.    
Male[n=110]
94%
Female [n=7]
6%
Sex Distribution [N=117]
B. ETIOLOGY
Table 3 - Etiology
Etiology No.of cases 
Gall Stone 4 
Alcohol 90 
unknown 23 
The tabular column 3 shows the different causes of the acute 
pancreatitis in prevalent in our population. In our area the most 
common cause is alcohol. Next it is due to some unknown causes. The 
unknown cause may be drugs, increase in cholesterol and 
hypercalcemia. These unknown causes need further analysis, even in 
unknown causes some patients had history of consumption of alcohol 
during the earlier days and had stopped consumption of alcohol in 
recent years.  Next common cause is the gallstone. Number of patients 
who had gall stone pancreatitis is four. On linking with the etiology 
with the sex incidence we could find out that the gall stone pancreatitis 
is more common in the females.    
The above diagram shows the etiology of the acute pancreatitis in 
the percentage. The orange shaded area shows that the alcohol 
contributes the 77% of the etiology in acute pancreatitis. The brown 
shaded area gives the percentage of gall stone contributing to 
pancreatitis, it is about 3%. Out of 7 females 2 had gall stones 
pancreatitis. The gall stone pancreatitis is common in females. 
Unknown causes contribute to about 20%.  
Gall Stone
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Alcohol
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20%
Etiology [N=117]
C.SEVERE ACUTE PANCREATITIS(SAP) Vs DIFFEENT
PROGNOSTIC SCORE
Table 4 - Severe Acute Pan. vs Prognostic Score
RANSON 
SAP 
Total P VALUE 
Yes No 
<  3 14 67 81 
NS >= 3 11 25 36 
Total 25 92 117 
BISAP 
<  3 10 87 97 
NS 
>= 3 15 5 20 
Total 25 92 117 
CTSI 
<  3 17 61 78 
NS >= 3 8 31 39 
Total 25 92 117 
The above tabular column 6 shows the distribution of the SAP 
within and above the cut off value of the different prognostic score. 
Table 5 - Severe Acute Pain vs Prognostic Score
Study  SEN SPEC PPV NPV RR ODDS 
RANSON 44% 73% 31% 83% 1.768 2.106 
BISAP  60% 95% 75% 90% 7.275 26.100 
CTSI  32% 66% 21% 78% 0.941 0.926 
TABLE 4 shows the different scores of patients with SAP. 14 
patients with SAP had RANSONs score < 3 and 11 with SAP had 
RANSON score > 3. But only 10 patients with SAP had BISAP score < 3 
and 15 SAP patients had BISAP score > 3. CTSI score in 17 SAP was < 3 
and 8 patient with CTSI had > 3. 
So out of 25 SAP patient BISAP picked out 15 and RANSON 
picked 14 and CTSI picked only 8. 
On looking the sensitivity specificity, PPV, NPV, and the odds 
ratio BISAP score has the sensitivity of 60% and the CTSI has the least 
sensitivity of 32%. The specificity of the BISAP score is 95%.PPV and 
NPV of the BISAP score is 75%, 90% respectively. The odds ratio is 
26. Greater than 1 is said to significant. So BISAP score predicts the 
SAP well comparing the other score. 
The above bar diagram shows the relationship between the severe 
acute pancreatitis and the other prognostic score. The blue shaded area 
indicates the presence of the SAP and the red shaded area indicates the 
absence of the SAP. Among the RANSON score <3, SAP is present in 
12% and 57% had no SAP. On the other hand in the patients with 
BISAP score <3, 9% had SAP and 74% had no SAP. In the patients 
with BISAP score >=3, 15% had SAP and 4% had no SAP.  
<  3 >= 3 <  3 >= 3 <  3 >= 3
Ranson Bisap CTSI
SAP  Yes 12% 9% 9% 13% 15% 7%
SAP  No 57% 21% 74% 4% 52% 26%
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D) MORTALITY Vs THE PROGNOSTIC SCORE
Table 6 - Mortality vs Prognostic Score
RANSON 
Mortality 
Total P VALUE
Yes No 
<  3 3 78 81 
NS 
>= 3 4 32 36 
Total 7 110 117 
BISAP 
<  3 2 95 97 
<0.01 >= 3 5 15 20 
Total 7 110 117 
CTSI 
<  3 4 74 78 
NS >= 3 3 36 39 
Total 7 110 117 
  The above tabular column 6 shows the distribution of the 
mortality within and above the cut off value of the different prognostic 
score. 
Table 7 - Mortality vs Prognostic Score
Study SEN SPEC PPV NPV RR ODDS
RANSON 57% 71% 11% 96% 3.000 3.250 
BISAP 71% 86% 25% 98% 12.125 15.833
CTSI 43% 67% 8% 95% 1.500 1.542 
This type of analysis shows which type of score is better in 
predicting the mortality in acute pancreatitis patient. Out of total 7 deaths 
4 patients has RANSON score >=3 , 5 patients had BISAP score >=3 and 
3 patients had CTSI score >=3. The p value of the BISAP score is <0.01 
which shows the significant relationship between the BISAP score and 
the mortality. 
 Table 7 shows the sensitivity of the scores in predicting the 
mortality. It is highest for the BISAP score and it is 71% , the specificity 
of the score is 86% which is also the highest. While for the RANSON, 
BISAP score the sensitivity is 57% and 43%, the specificity is 71% and 
67% respectively. The PPV and NPV for the BISAP score is 25% and 
98% respectively. This shows that BISAP score predicts the mortality 
well when compared to the other score. 
The above bar diagram shows the relationship between the 
mortality and the various prognostic score. The mortality is three 
percent for the patients with RANSON score <3 and >=3. There is 
same percentage of mortality occurred in the patients with CTSI score 
<3 and >=3. But the mortality is 4% for the patient with BISAP score 
>=3. This is high when compared to other score. This indicates 
predicting accuracy of mortality by the BISAP score.  
<  3 >= 3 <  3 >= 3 <  3 >= 3
Ranson Bisap CTSI
Mortality Yes 3% 3% 2% 4% 3% 3%
Mortality No 67% 27% 81% 13% 63% 31%
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E) PANCRETIC NECROSIS (PANCREATIC NECROSIS) Vs 
PROGNOSTIC SCORE
Table 8 - Pancreatic Necrosis vs Prognostic Score
RANSON 
P Nec 
Total 
P 
VALUE Present Absent 
<  3 8 73 81 
NS >= 3 8 28 36 
Total 16 101 117 
BISAP 
<  3 9 88 97 
< 0.05 >= 3 7 13 20 
Total 16 101 117 
CTSI 
<  3 2 76 78 
<0.001 >= 3 14 26 39 
Total 16 102 117 
The above tabular column 6 shows the distribution of the 
Pancreatic necrosis within and above the cut off value of the different 
prognostic score. 
Table 9 - Pancreatic Necrosis vs Prognostic Score
Study  SEN SPEC PPV NPV RR ODDS
RANSON 50% 72% 22% 90% 2.250 2.607 
BISAP  44% 87% 35% 91% 3.772 5.265 
CTSI  88% 75% 35% 97% 13.650 20.462
TABLE 8 shows the score which can predict the Pancreatic 
necrosis. Since pancreatic necrosis is a CT finding naturally it shows 
that CTSI is good in predicting the pancreatic necrosis. Out of the 117 
patients 16 patients had pancreatic necrosis. Out of the 16 patients 14 
patients had CTSI score >=3 and only 2 patients had score <3. The P 
value of the BISAP score in predicting the mortality is <0.05. But the P 
value of the CTSI score in predicting the pancreatic necrosis is <0.001. 
This indicates strong relationship between the CTSI score and 
pancreatic necrosis.  
 The sensitivity and the specificity of the CTSI score in 
predicting the pancreatic necrosis is 88% and 75% respectively. The 
odds ratio is 20 which show the strongest relationship between the 
CTSI and the pancreatic necrosis.  
The above bar diagram shows that the 12% of the patients with 
CTSI >=3 had Pancreatic necrosis. Only 2% of the patients with score < 
3 had Pancreatic necrosis. 7% of the patients with RANSON score <3 and 
>=3 had pancreatic necrosis. 8% of the patients with BISAP score < 3 
had pancreatic necrosis. Six percent of the patients with score >=3 had 
pancreatic necrosis. The bar diagram finally shows the highest predicting 
value for pancreatic necrosis by the CTSI.  
F)MORBIDITY
 Morbidity is assessed by number of days patients stayed in the hospital. 
The mean and standard deviation is 9.03+/- 3.42 days. The overall days patients 
stayed in the hospital has no significant relationship with the scoring system.  
<  3 >= 3 <  3 >= 3 <  3 >= 3
Ranson Bisap CTSI
P nec Present 7% 7% 8% 6% 2% 12%
P nec Absent 62% 24% 75% 11% 65% 22%
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AREA UNDER CURVES 
AUC 1 COMPARISON OF SCORING SYSTEMS IN PREDICATING
SEVERE ACUTE PANCREATITIS
AUC FOR SAP
 The above graph is the ROC for SAP. The green colored line shows 
the BISAP score, the blue colored line shows the RANSON score, the 
pink colored indicates the CTSI and the violet colored line is the 
reference line. The BISAP score line is high above all line, the area 
covered below the line is maximum when compared with other line    
Source of the graph is RANSON, BISAP, CTSI group. The AUC is 0.773 
for BISAP which is the maximum when compared to other scores (table 
14). The standard error of the same score is 0.0653 and the 95% 
confidence interval is 0.650 to 0.896. The AUC is least for CTSI group in 
predicting the SAP. 
Table 10 - Area Under the Curve for SAP
Test Result 
Variable(s) 
Area 
Std. 
Errora
Asymptotic 
Sig.b
Asymptotic 95% 
Confidence Interval 
Lower 
Bound 
Upper 
Bound 
RANSON 
grp 0.584 0.066 0.198 0.454 0.714 
BISAP grp 0.773 0.063 0.000 0.650 0.896 
CTSI grp 0.492 0.065 0.897 0.364 0.619 
 The Table 10 shows that BISAP score is good in predicting the 
SAP in the acute pancreatitis patient. 
AUC 2 COMPARISION OF THE SCORING SYSTEM IN 
PREDICTING THE MORTALITY
The ROC curve 2 finds out the score which predicts the mortality 
in better way. The above graph is the ROC for mortality. The source of 
the graphs is RANSON, BISAP, CTSI group. The green colored line 
shows the BISAP score, the blue colored line shows the RANSON 
score, the pink colored indicates the CTSI and the violet colored line is 
the reference line. The BISAP score line is high above all line, the area 
covered below the line is maximum when compared with other line. 
Table 11 - Area Under the Curve for mortality
Test Result 
Variable(s) 
Area 
Std. 
Errora
Asymptotic 
Sig.b
Asymptotic 95% 
Confidence Interval 
Lower 
Bound 
Upper 
Bound 
RANSON grp 0.640 0.112 0.215 0.420 0.860 
BISAP grp 0.789 0.102 0.011 0.589 0.989 
CTSI grp 0.551 0.115 0.654 0.326 0.776 
  The AUC for the BISAP is 0.789 and it has the standard error of 
0.102. the AUC for the RANSON and the CTSI is 0.640 and 0.551 
respectively. The BISAP score has the CI of 0.589 to 0.989. 
So this clearly suggests that BISAP score is better when compared 
to the other score.  
AUC 3 COMPARING THE SCORING SYSTEM IN PREDICTING 
THE PANCREATIC NECROSIS
The ROC curve 2 finds out the score which predicts the 
pancreatic necrosis. The above graph is the ROC for pancreatic 
necrosis. The source of the graph is  RANSON, BISAP, CTSI group. 
The green colored line shows the BISAP score, the blue colored line 
shows the RANSON score, the pink colored indicates the CTSI and the 
violet colored line is the reference line. The CTSI score line is high 
above all line, the area covered below the line is maximum when 
compared with other line 
Table 11 - Area Under the Curve for pancreatic necrosis
Test Result 
Variable(s) 
Area 
Std. 
Errora
Asymptotic 
Sig.b
Asymptotic 95% 
Confidence Interval 
Lower 
Bound 
Upper 
Bound 
RANSON grp 0.611 0.079 0.153 0.457 0.766 
BISAP grp 0.654 0.082 0.048 0.494 0.815 
CTSI grp 0.814 0.055 0.000 0.706 0.921 
The ROC graph 3 finds which score predicts the pancreatic 
necrosis. The AUC for CTSI group is 0.814 and the 95% CI for the same 
group is 0.706 and 0.921. AUC is least for the RANSON group and it is 
0.611. BISAP group has the AUC of 0.654 and the standard error is 
0.082.This shows that CTSI predicts the pancreatic necrosis well. 
ATLANDA CLASSIFICATION ANALYSIS
The Atlanta classification classifies the acute pancreatitis into 
necrotic pancreatitis and edematous pancreatitis. The classification uses 
the above parameter to predict the mortality. In this study of 117 patients 
necrotic pancreatitis is 16 i.e. 14% and the rest is edematous pancreatitis 
accounting to about 86%.        
The above bar diagram compares the mortality and the pancreatitis 
necrosis and the mortality. Among 16 patients who had pancreatic 
necrosis 3 died and the others survived. Among the rest 4 died and 83% 
survived. Only 11% of the patients who had acute severe pancreatitis 
survived (bar diagram). 
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This shows there relationship between the pancreatic necrosis and 
the mortality. 
PANCREATIC NECROSIS vs SEVERE ACUTE PANCREATITIS
Table 12 - PANCREATIC NECROSIS VS SAP
P Nec 
SAP 
Yes No Total (%) 
Present 8 8 16 14%
Absent 17 84 101 86%
Total 25 92 117 100%
 This tabular column 12 gives the analysis between the pancreatic 
necrosis and the SAP. Out of the 25 SAP patients pancreatic necrosis 
present in 8 patients and absent in 17 patients. On the other hand out of 
92 patients with no SAP, 8 patients had pancreatic necrosis. 
PAN NEC VS SAP & MORTALITYAUC
This graph discusses the factor pancreatic necrosis in predicting the 
mortality and the severity since the pancreatic necrosis is the only factor used in
PAN NEC VS SAP & MORTALITYAUC
the ATLANDA classification. The green colored line indicates the SAP, the 
violet line indicated the mortality and the other line is the mortality. The AUC 
for the factor mortality within the pancreatic necrosis is 0.574, which is much 
less when compared to the AUC for the severity. This suggests that the patients 
with the pancreatic necrosis the severe pancreatitis is likely. 
DISCUSSION
1 AGE COMPARISON
Table 13 - Age Comparison
S.No STUDY 
MEAN 
AGE 
1 PRESENT STUDY 39+/-11 
2 
VIKESH SINGH AND 
GROUP13 
52+/-16 
3 GEORGIOS AND GROUP 52+/-14 
  The mean age with SD of study group is 39+/-11 and inter quartile range 
is 16-72. This is less when compared to other. This might be due to the etiology 
alcohol is more prevalent in the younger age group. 
2.  ETIOLOGY 
In our study the most common etiology is alcohol but in other study the 
most common etiology is gall stones. In our study gall stone is most common 
etiology in females.   
2. MEDIAN HOSPITAL STAY
Table 14 – Median Hospitals
S.No STUDY 
HOSPITAL 
STAY(days) 
1 PRESENT 9 
2 A.O FARRELL 7 
Compare to the study done by AO Farrell25 the hospital stay is increased 
with our study. 
4. MORTALITY COMPARITION
Table 15 – Mortality Comparison 
S.No STUDY MORTALITY% 
1 PRESENT STUDY 5.9 
2 VIKESH SINGH AND GROUP 3.5 
3 GEORGIOS AND GROUP 3.5 
4 LOSADA M AND GROUP12 9 
5 SHEN AND GROUP11 2.7 
  Table 16 - SENSITIVITY, SPECIFICITY,PPV,NPV OF BISAP SCORE IN 
PREDICTING THE MORTALITY IN DIFF. STUDIES
S.NO STUDY 
SENSITIVITY 
% 
SPECIFICITY 
% 
PPV% NPV%
1 
PRESENT 
STUDY 
71 86 25 98 
2 
VIKESH SINGH 
AND GROUP 
71 83 17.5 99 
3 
GEORGIOS AND 
GROUP15 
57.1 87.6 15.5 98 
Table 17 - AUC OF BISAP SCORE IN PREDICTING THE MORTALITY IN 
DIFF STUDIES
S.No STUDY AUC 
1 PRESENT STUDY 0.78 
2 
VIKESH SINGH AND 
GROUP 
0.83 
3 GEORGIOS AND GROUP 0.82 
The overall mortality of the study is 5.9 it is higher when compared to the 
Vikesh Singh and group, Georgios and group but lower than the LOSADA M 
and group. This might be due to the many factors such as availability of the 
intensive care in the developing country, other co morbid factor. The sensitivity, 
specificity, PPV, NPV of the BISAP score in predicting the mortality is 
consistent with study done by Vikesh Singh and group. The sensitivity is higher 
when compared to the GEORGIOS and group study. This suggests that BISAP 
score does well in predicting the mortality. AUC for predicting the mortality by 
the BISAP score is also more or less consistent with the other study. 
4. SAP COMPARISON IN DIFFERENT STUDIES 
Table 18 - SENSITIVITY, SPECIFICITY, PPV, NPV OF BISAP SCORE IN 
PREDICTING THE SAP
S.NO STUDY SENSITIVITY SPECIFICITY PPV NPV
1 PRESENT STUDY 60 95 75 90 
2 
GEORGIOS AND 
GROUP15 
35.5 92.4 57.7 84.3 
The above tabular column 19 compares the sensitivity, specificity, PPV, NPV 
of the BISAP score in predicting the SAP with other study. The sensitivity and 
specificity in the present study is 60% and 95% respectively. While in the 
georgious group the same is 35-5% and 92.4% respectively. The specificity is 
consistent when compared with present study.  
Table – 19 AUC OF BISAP SCORE IN PREDICTING THE SAP IN DIFF 
STUDIES
S.NO STUDY AUC 
1 PRESENT STUDY 0.773 
2 GEORGIOS AND GROUP 0.8I 
In our study BISAP score performed well compared to the Georgiou and 
group study. However the AUC of the later study is more when compared with 
our study. SAP also well predicted by BISAP in our study. This indicates 
BISAP score is able to predict development of the organ failure in first 24 hour. 
In The study performed by Vikesh shingh it was found that patients with > = 3 
score in BISAP had 7.4 times more prone to develop SAP. 
Table 20 - SENSITIVITY, SPECIFICITY, PPV, NPV OF BISAP
SCORE IN PREDICTING THE PANCREATIC NECROSIS IN DIFF 
STUDIES
S. NO SCORE STUDY SENTI SPECI PPV NPV
1 
BISAP 
PRESENT STUDY 50 72 22 90 
GEORGIOS AND 
GROUP 
33.3 90.6 46.6 84.9 
2 
CTSI 
PRESENT STUDY 88 75 35 97 
GEORGIOS AND 
GROUP 
97.2 75.8 59.3 98.7 
 Pancreatic necrosis is well predicted by the CTSI in both the study. But 
BISAP score has increased sensitivity in predicting the pancreatic necrosis 
when compared to the GEORGIOS and group. 
5. ATLANDA CLASSIFICATION ANALYSIS
Table 21 – Atlanta Classification analysis
S.No STUDY NECROTIC 
PAN 
OTHERS 
1 PRESENT STUDY 14 86 
2 LOSADA M STUDY12 32 68 
According to Atlanta classification 80% of the pancreatitis belongs to 
acute edematous pancreatitis i.e. the mild form. Rest of the pancreatitis belongs 
to the necrotizing pancreatitis. Our study is consistent with the Atlanta 
classification. Further the Atlanta classification states that mortality in the 
necrotizing type is 15%-30%, in our study out of 16 patients who had the 
necrotizing 3 died. This accounts to about 18.75% which is also within the 
limits of the classification. 
CONCLUSION
 To conclude BISAP score is simple and it is the better scoring system in 
predicting the prognosis when compared to other score. The BISAP score has 
many advantages when compared to other scoring system. The advantages are 
as follows 
1) It is simple in calculating the score the components are clinically relevant 
and easy to obtain. 
2) It uses the 24 hrs data to predict the prognosis of the acute pancreatitis 
patient. But in RANSON score 48hrs data has to be collected. 
3) BISAP SCORE gives weightage to the immune response of the injury and 
includes the age criteria. 
4) BISAP score is used to triage the patient to closer observation and to asses 
which patients need closer monitoring. 
Atlanta classification also holds good for the classify the pancreatitis 
into mild and severe disease also holds good to assess the prognosis of the 
acute pancreatitis. On the whole when BISAP scoring system is combined 
with the ct scan then the assessment of the acute pancreatitis becomes very 
accurate. When combined they can used triage the patient, anticipate the 
complications, assess the severity, predict the mortality.  
SUMMARY
1. In our study occurrence of the pancreatitis is common in the age 
group is 39+/-11. 
2. Most common etiology is alcohol it is about77%. 
3. In our community men are most affected than women. 
4. Median hospital stay in our community for acute pancreatitis is 
about 9+/-3days. 
5. According to ATLANDA score 86% had mild disease. 
6. On the whole BISAP score is better in predicting the mortality an 
severe disease .  
7. CTSI predicted the necrotic pancreatitis in a better way. 
8. Among the pancreatic necrosis the mortality is 3%. 
9. Among the pancreatic necrosis patient 7% had severe acute 
pancreatitis. 
10. The sensitivity and specificity of the BISAP score in 
predicting the severe acute pancreatitis is 60%, 95%. 
11. The sensitivity and specificity of the BISAP score in 
predicting the mortality is 71%, 86%. 
12. The sensitivity and specificity of the CTSI score in predicting 
the pancreatic necrosis is 88%, 75%.  
The below tabular column 23 summarizes the ability of the prognostic 
score in predicting the SAP.  On the whole the SAP is 21%. In the patients with  
score >=3 in RANSON, BISAP ,CTSI scoring system  there is 31%,17%,33%  
SAP respectively.  
Table 22 - SEVERE ACUTE PAN VS PROGNOSTIC SCORE
RANSON
SAP 
Total P VALUE 
Yes No 
<  3 12% 57% 69% 
NS 
>= 3 9% 21% 31% 
Total 21% 79% 100% 
BISAP 
<  3 9% 74% 83% 
NS 
>= 3 13% 4% 17% 
Total 21% 79% 100% 
CTSI 
<  3 15% 52% 67% 
NS 
>= 3 7% 26% 33% 
Total 21% 79% 100% 
The below tabular column 24 summarizes the ability of the prognostic score in 
predicting the mortality. On the whole the mortality is 5.9%. In the patients with  
score >=3 in RANSON, BISAP ,CTSI scoring system  there is 31%,17%,34%  
mortality respectively.  
TABLE 23-MORTALITY VS PROGNOSTIC SCORE
RANSON 
Mortality 
Total P VALUE
Yes No 
<  3 3 78 81 
NS 
>= 3 4 32 36 
Total 7(5.9%) 110 117 
BISAP 
<  3 2 95 97 
<0.01 >= 3 5 15 20 
Total 7(5.9%) 110 117 
CTSI 
<  3 4 74 78 
NS >= 3 3 36 39 
Total 7(5.9%) 110 117 
The below tabular column 25 summarizes the ability of the prognostic score in 
predicting the pancreatic necrosis. On the whole the pancreatic necrosis is 14%. 
In the patients with  score >=3 in RANSON, BISAP ,CTSI scoring system  
there is 31%,17%,34%  pancreatic necrosis respectively.   
Table 24 - PANCREATIC NECROSIS VS PROGNOSTIC 
SCORE
RANSON
P Nec 
Total P VALUE 
Present Absent 
<  3 7% 62% 69% NS 
>= 3 7% 24% 31% 
Total 14% 86% 100% 
BISAP 
<  3 8% 75% 83% < 0.05 
>= 3 6% 11% 17% 
Total 14% 86% 100% 
CTSI 
<  3 2% 65% 67% <0.001 
>= 3 12% 22% 34% 
Total 14% 87% 101% 
 The below tabular column summarizes the AUC of the various scoring 
system in predicting the SAP, mortality, pancreatic necrosis. 
Table 25 - AREA UNDER CURVE
SAP Area 95% CI p value 
RANSON 0.584 0.454-0.714 NS 
BISAP 0.773 0.650-0.896 <0.001 
CTSI 0.492 0.364-0.619 NS 
Mortality
RANSON 0.640 0.420-0.860 NS 
BISAP 0.789 0.589 - 0.989 <0.05 
CTSI 0.551 0.326 - 0.776 NS 
P Nec 
RANSON 0.611 0.457 - 0.766 NS 
BISAP 0.654 0.494 - 0.815 <0.05 
CTSI 0.814 0.706 - 0.921 <0.001 
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PERFORMA FOR ACUTE PANCREATITIS
NAME;                                      AGE:            SEX:              PHONE NO:                   
D.O.A: 
ADDRESS: 
COMPLAINTS: 
HISTORY OF PRESENT ILLNESS: 
HISTORY OF PAST ILLNESS: 
GENRAL EXAMINATION: 
ABDOMEN EXAMINATION: 
 Inspection 
 Palpation 
 Percussion 
 Auscultation 
SERUM AMLYASE:
1. RANSON SCORE 
ADMISSION                                                          48 HRS 
1 AGE                                                                       1. HB DECLINE: 
2 W.B.C:                                                                   2. BUN INCREASE 
3 SUGAR                                                                  3. FLUID REPLACED 
4AST:                                                                        4. PAO2 
5LDH:                                                                        5. SERUM CALCIUM 
2. BISAP SCORING
BUN:                       GCS:                        AGE:                      PLEURAL 
EFFUSION: 
SIRS 
               TEMP:           RR:                 PR:                    WBC:         
3. BALTHAZAR SCORE:
1 NORMAL CT 
2 DIFFUSE ENLARGEMENT OF PANCREAS  
3 PANCREATIC GLAND ABNORMALITY &INFLATION 
4 FLUID COLLECTIONS IN SINGLE LOCATION 
5 > 2 FLUID COLLECTION 
% OF PANCREATIC NECROSIS 
4. ATLANDA CLASSIFICATION;
1 ACUTE EDEMATOUS PANCREAS; 
2 ACUTE NECROTIZING PANCREAS 
1 RANSON SCORE    ETIOLOGY 
3 BISAP SCORING 
5 BALTHAZAR SCORE: 
SAP 
PAN NEC 
MORTALITY                                       MORBIDITY 
106
BISAP SCORE VALUES 
Sl.no
. Name Age 
BuN 
Mg/dl
GCS 
Fr 15 AGE
PL.E
F 
SIR
S BISAP SAP 
Mort
al 
Panc 
Nec 
1 VIJAY 37 28 15 0 0 1 2 0 0 0 
2 MATHEWS 63 30 15 1 1 1 4 1 1 1 
3 SIVA 16 21 15 0 0 1 1 0 0 0 
4 KULANTHAISAMY 43 22 15 0 0 0 0 0 0 0 
5 GOWRISANKER 23 30 10 0 0 1 3 1 1 0 
6 RAMESHKUMAR 25 29 15 0 0 1 2 0 0 0 
7 HUSSAIN 38 28 15 0 0 1 2 0 0 0 
8 CHINNAN 53 27 15 0 0 0 1 0 0 0 
9 KARUPPUSAMY 48 30 15 0 0 1 2 0 0 0 
10 PRAKASH 32 31 10 0 0 1 3 1 0 0 
11 KARUPPUSAMY 44 30 15 0 0 1 2 0 0 0 
12 KARTHIKAYEN 65 29 15 1 0 0 2 0 0 0 
13 MURUGESAN 23 32 10 0 1 1 4 1 0 1 
14 ARUMUGAM 62 25 15 1 0 0 1 0 0 0 
15 SENTHIL KUMAR 65 24 15 1 1 1 5 0 0 0 
16 KRISHNAN 25 18 15 0 0 0 0 0 0 0 
17 MUTHUKUMARSAY 48 28 15 0 0 1 2 0 0 0 
18 JOHN BOSCO 20 25 15 0 0 1 2 0 0 0 
19 SENTHIL KUMAR 22 34 15 0 0 0 1 1 0 1 
20 SIDDIQUE 28 31 15 0 0 1 2 0 0 0 
21 MOHAMAD 39 23 15 0 0 0 1 0 0 0 
22 GOWRISANKER 37 28 15 0 0 0 1 0 0 1 
23 RAMESH 33 30 10 0 0 0 2 0 0 0 
24 BAKER 44 22 15 0 0 0 0 0 0 0 
25 GANESH 26 33 10 0 0 1 3 0 0 0 
26 SURESH 42 28 15 0 0 1 2 1 0 1 
27 ALAGAPPAN 45 27 15 0 0 1 2 0 0 0 
28 RAMALINGAM 39 28 10 0 0 0 2 0 0 0 
29 SENTHIL VEL 22 29 15 0 0 0 1 0 0 0 
30 BANNARI 34 33 15 0 1 1 3 1 0 0 
31 KANNAN 44 30 15 0 0 0 1 0 0 0 
32 THANGARAJ 27 21 15 0 0 0 0 0 0 0 
33 DURAIRAJ 32 29 15 0 0 1 2 0 0 0 
34 ARUMUGAM 23 28 15 0 0 1 2 0 0 0 
35 KARRUPUSAMY 52 33 15 0 0 0 1 0 0 0 
36 VELUSAMY 38 34 5 0 1 1 4 1 1 0 
37 CHANDRAKALA 23 26 15 0 0 1 2 0 0 1 
38 RAKIYYAPAN 37 27 15 0 0 0 1 0 0 0 
39 SARAGANAN 39 29 15 0 0 1 2 0 0 0 
40 UHAITHULA 39 21 15 0 0 0 0 0 0 0 
41 VELAVANTHAN 50 26 15 0 0 0 2 0 0 0 
42 SUBRAMANI 45 33 5 0 1 1 4 0 0 1 
43 AROKIARAJ 39 28 15 0 0 1 2 1 0 0 
44 SELVAVATHY 41 28 15 0 0 0 1 0 0 0 
45 VIJAY 45 27 15 0 0 1 2 0 0 0 
46 LAKSHMANAN 49 29 15 0 1 1 3 1 0 0 
47 SELVAM 45 26 15 0 0 0 1 0 0 0 
48 SASIKUMAR 39 27 15 0 0 1 2 0 0 0 
49 SELVARAJ 51 33 10 0 1 1 4 0 0 1 
50 GOVINDHARAJ 48 29 15 0 0 1 2 0 0 0 
51 SHANTHI 35 28 15 0 0 0 1 0 0 0 
52 MOORTHY 48 31 15 0 1 1 3 1 0 0 
53 POONKODI 50 26 15 0 0 1 2 0 0 0 
54 SIVAKUMAR 45 27 15 0 0 0 1 1 0 0 
55 SIVARAJ 44 29 15 0 0 1 2 0 0 0 
56 ANTONY LEO 40 28 15 0 0 0 1 0 0 0 
57 SARAVANA KU 34 30 15 0 0 1 2 0 0 0 
58 KATHARARAYAN45 40 22 15 0 0 0 0 0 0 0 
59 GANESH 39 30 9 0 0 1 3 1 0 0 
60 GOVINDHARAJ 35 28 15 0 0 0 1 0 1 0 
61 MURAGAN 40 22 15 0 0 0 0 0 0 0 
62 ARUKANIYAMAL 35 30 15 0 0 0 1 0 0 1 
63 ALLGAPAN 38 29 15 0 0 1 2 0 0 0 
64 KAMARAJ 62 24 0 1 0 0 1 0 0 0 
65 KATTHIRVEL 41 27 15 0 0 1 2 0 0 0 
66 SIVAKUMAR 51 22 15 0 0 0 0 0 0 0 
67 SELVARAJ 32 31 5 0 1 1 4 1 1 0 
68 AL BATHA 48 26 15 0 0 0 1 0 0 0 
69 SABUTHEEN 45 29 15 0 0 1 2 0 0 1 
70 MANI 42 30 15 0 0 0 1 0 0 0 
71 RANI 46 33 15 0 0 1 2 1 0 1 
72 MURUGESH 43 19 15 0 0 0 0 0 0 0 
73 SRINIVASAN 26 22 15 0 0 0 0 0 0 0 
74 SANMUGASUNDRAM 34 30 15 0 0 0 1 0 0 0 
75 KUPPURAJ 47 33 5 0 1 1 4 1 0 1 
76 MURUGAIH 21 29 15 0 0 1 2 0 0 0 
77 BALAMURUGAN 35 27 15 0 0 1 1 1 1 0 
78 PRABU 23 28 15 0 0 1 2 0 0 0 
79 RAJENDRAN 47 32 15 0 1 1 3 0 0 0 
80 SELVAKUMAR 54 24 15 0 0 0 0 0 0 0 
81 PARAMASIVA 18 27 15 0 0 1 2 1 0 0 
82 UDYAKUMAR 36 28 15 0 0 1 2 1 0 0 
83 NIRMALDEVAN 49 21 15 0 0 0 0 0 0 0 
84 CHANDRAN 36 28 15 0 0 1 2 0 0 0 
85 SUBBAIYA 33 26 15 0 0 0 1 0 0 1 
86 ABDULKATAR 53 33 15 0 1 1 3 1 0 0 
87 YESIN 42 31 15 0 0 1 2 0 0 0 
88 JEGANATHAN 42 27 15 0 0 0 1 0 0 0 
89 MANIKANDAN 44 21 15 0 0 1 0 0 0 0 
90 ELANGOVAN 48 26 15 0 0 1 2 0 0 0 
91 RANJENDRAN 20 19 15 0 0 0 0 0 0 0 
92 KANAGARAJ 45 28 15 0 0 0 1 0 0 0 
93 NAGARAJAN 72 31 15 1 0 1 2 0 0 0 
94 RAMESH 40 28 15 0 0 0 1 0 0 0 
95 ARJUNAN 20 26 15 0 0 1 4 1 0 0 
96 KANNAPAN 45 29 15 0 0 1 2 0 0 0 
97 MOHANRAJ 32 21 15 0 0 0 0 0 0 0 
98 KANDSSAMY 45 31 15 0 0 1 2 0 0 1 
99 RANGARAJ 21 19 15 0 0 0 0 0 0 0 
100 NANTHAKUMAR 56 29 15 0 0 1 2 0 0 0 
101 ROBERT 26 44 15 0 0 1 2 1 1 1 
102 PONNAIYAN 64 31 15 1 0 0 1 0 0 0 
103 GANESAN 32 34 10 0 1 1 4 0 0 0 
104 VAIYAPURI 18 28 15 0 0 1 2 0 0 0 
105 BALAKRISHNAN 40 30 15 0 0 0 1 1 0 0 
106 ARIVALAGAN 28 27 15 0 0 1 2 0 0 0 
107 VASANTHAN 32 18 15 0 0 0 0 0 0 0 
108 KANTHARAJ 53 26 15 0 0 1 2 0 0 0 
109 RAVICHANDRAN 37 29 15 0 0 1 2 0 0 0 
110 SARAGAM 24 30 15 0 0 1 2 0 0 0 
111 VELAVANTHAN 48 29 15 0 0 0 1 0 0 0 
112 SENTHILVEL 47 28 15 0 0 1 2 0 0 0 
113  VINAYAK 31 32 10 0 1 1 4 1 0 1 
114 ULAGANATHAN 35 30 15 0 0 1 2 0 0 0 
115 NARAYANAN 42 29 15 0 0 0 1 0 0 0 
116 SANKARAN 38 29 15 0 0 1 2 1 0 0 
117 JABAKUMAR 45 21 15 0 0 0 0 0 0 0 
CTSI VALUES
Sl.no. Name Age CT SCAN REPORT CTSI Panc Nec 
1 VIJAY 37 B 2 0 
2 MATHEWS 63 D 5 1 
3 SIVA 16 B 2 0 
4 KULANTHAISAMY 43 C 4 0 
5 GOWRISANKER 23 A 1 0 
6 RAMESHKUMAR 25 C 4 0 
7 HUSSAIN 38 B 2 0 
8 CHINNAN 53 A 1 0 
9 KARUPPUSAMY 48 B 2 0 
10 PRAKASH 32 A 1 0 
11 KARUPPUSAMY 44 C 4 0 
12 KARTHIKAYEN 65 C 4 0 
13 MURUGESAN 23 B 2 1 
14 ARUMUGAM 62 A 1 0 
15 SENTHIL KUMAR 65 C 4 0 
16 KRISHNAN 25 B 2 0 
17 MUTHUKUMARSAY 48 C 4 0 
18 JOHN BOSCO 20 B 2 0 
19 SENTHIL KUMAR 22 D 7 1 
20 SIDDIQUE 28 A 1 0 
21 MOHAMAD 39 A 1 0 
22 GOWRISANKER 37 D 5 1 
23 RAMESH 33 B 2 0 
24 BAKER 44 B 2 0 
25 GANESH 26 C 4 0 
26 SURESH 42 D 5 1 
27 ALAGAPPAN 45 B 2 0 
28 RAMALINGAM 39 B 2 0 
29 SENTHIL VEL 22 A 1 0 
30 BANNARI 34 B 2 0 
31 KANNAN 44 C 4 0 
32 THANGARAJ 27 A 1 0 
33 DURAIRAJ 32 C 4 0 
34 ARUMUGAM 23 B 2 0 
35 KARRUPUSAMY 52 B 2 0 
36 VELUSAMY 38 A 1 0 
37 CHANDRAKALA 23 D 5 1 
38 RAKIYYAPAN 37 B 2 0 
39 SARAGANAN 39 C 4 0 
40 UHAITHULA 39 B 2 0 
41 VELAVANTHAN 50 C 4 0 
42 SUBRAMANI 45 D 5 1 
43 AROKIARAJ 39 B 2 0 
44 SELVAVATHY 41 B 2 0 
45 VIJAY 45 A 1 0 
46 LAKSHMANAN 49 B 2 0 
47 SELVAM 45 A 1 0 
48 SASIKUMAR 39 B 2 0 
49 SELVARAJ 51 D 7 1 
50 GOVINDHARAJ 48 B 2 0 
51 SHANTHI 35 C 4 0 
52 MOORTHY 48 B 2 0 
53 POONKODI 50 C 4 0 
54 SIVAKUMAR 45 A 1 0 
55 SIVARAJ 44 B 2 0 
56 ANTONY LEO 40 A 1 0 
57 SARAVANA KU 34 C 4 0 
58 KATHARARAYAN45 40 B 2 0 
59 GANESH 39 B 2 0 
60 GOVINDHARAJ 35 D 5 0 
61 MURAGAN 40 A 1 0 
62 ARUKANIYAMAL 35 C 4 1 
63 ALLGAPAN 38 B 2 0 
64 KAMARAJ 62 A 1 0 
65 KATTHIRVEL 41 B 2 0 
66 SIVAKUMAR 51 B 2 0 
67 SELVARAJ 32 A 1 0 
68 AL BATHA 48 B 2 0 
69 SABUTHEEN 45 D 5 1 
70 MANI 42 A 1 0 
71 RANI 46 D 5 1 
72 MURUGESH 43 B 2 0 
73 SRINIVASAN 26 B 2 0 
74 SANMUGASUNDRAM 34 B 2 0 
75 KUPPURAJ 47 D 5 1 
76 MURUGAIH 21 A 1 0 
77 BALAMURUGAN 35 B 2 0 
78 PRABU 23 C 4 0 
79 RAJENDRAN 47 A 1 0 
80 SELVAKUMAR 54 C 4 0 
81 PARAMASIVA 18 B 2 0 
82 UDYAKUMAR 36 B 2 0 
83 NIRMALDEVAN 49 A 1 0 
84 CHANDRAN 36 B 2 0 
85 SUBBAIYA 33 D 5 1 
86 ABDULKATAR 53 C 4 0 
87 YESIN 42 A 1 0 
88 JEGANATHAN 42 C 4 0 
89 MANIKANDAN 44 B 2 0 
90 ELANGOVAN 48 A 1 0 
91 RANJENDRAN 20 B 2 0 
92 KANAGARAJ 45 C 4 0 
93 NAGARAJAN 72 B 2 0 
94 RAMESH 40 A 1 0 
95 ARJUNAN 20 C 4 0 
96 KANNAPAN 45 B 2 0 
97 MOHANRAJ 32 A 1 0 
98 KANDSSAMY 45 D 5 1 
99 RANGARAJ 21 B 2 0 
100 NANTHAKUMAR 56 B 2 0 
101 ROBERT 26 D 5 1 
102 PONNAIYAN 64 A 1 0 
103 GANESAN 32 C 4 0 
104 VAIYAPURI 18 B 2 0 
105 BALAKRISHNAN 40 B 2 0 
106 ARIVALAGAN 28 A 1 0 
107 VASANTHAN 32 C 4 0 
108 KANTHARAJ 53 B 2 0 
109 RAVICHANDRAN 37 B 2 0 
110 SARAGAM 24 C 4 0 
111 VELAVANTHAN 48 B 2 0 
112 SENTHILVEL 47 A 1 0 
113  VINAYAK 31 B 2 1 
114 ULAGANATHAN 35 A 1 0 
115 NARAYANAN 42 C 4 0 
116 SANKARAN 38 B 2 0 
117 JABAKUMAR 45 A 1 0 
A- CTSI SCORE- 1 , CT REPORT- ACUTE EDEMATOUS PANCREATITIS 
B- CTSI SCORE-2 , CT REPORT-PANCREATIC GLAND ABNORMALITY AND 
PERIPANCREATIC INFLAMATIOM 
C- CTSI SCORE -4 , C TREPORT-EXTRA PANCREATIC NECROSIS WITH FLUID 
COLLECTIONS 
D- CTSI SCORE - > 4 CT REPORT- NECROTIC PANCREATITS
E-
F- RANSON SCORE MASTER CHART
Sl.no
. Name 
Ag
e 
AG
E 
WB
C 
BLS 
AS
T 
AL
T 
HB 
BU
N 
BAS
E 
DEFI
FLUI
D 
REPL 
PaO
2 
CAL Ranson
SA
P 
Etio 
Mort
a 
1 VIJAY 37 0 0 1 0 0 0 0 0 1 0 0 2 0 U1 0 
2 MATHEWS 63 1 1 0 0 0 0 1 0 1 0 1 5 1 A 1 
3 SIVA 16 0 1 1 0 0 0 0 0 0 0 0 2 0 A 0
4 KULANTHAISAMY 43 0 0 1 0 0 0 0 0 1 0 0 2 0 A 0 
5 GOWRISANKER 23 0 0 0 0 0 0 0 0 1 0 0 1 1 U2 1 
6 RAMESHKUMAR 25 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
7 HUSSAIN 38 0 0 0 0 0 0 0 0 1 0 0 1 0 A 0 
8 CHINNAN 53 0 1 0 0 0 0 0 0 0 0 0 1 0 A 0 
9 KARUPPUSAMY 48 0 1 1 0 0 0 0 0 0 0 0 2 0 U3 0 
10 PRAKASH 32 0 1 0 0 0 1 1 1 1 0 0 5 1 A 0 
11 KARUPPUSAMY 44 0 0 0 0 0 0 0 0 1 0 0 1 0 A 1 
12 KARTHIKAYEN 65 1 0 1 0 0 0 0 0 1 0 0 3 0 U4 0 
13 MURUGESAN 23 0 1 1 1 1 0 0 1 1 1 0 6 1 A 0 
14 ARUMUGAM 62 1 0 0 0 0 0 0 0 1 0 0 2 0 G 0 
15 SENTHIL KUMAR 65 1 0 0 0 0 0 0 0 1 0 0 2 0 A 0 
16 KRISHNAN 25 0 0 0 0 0 0 0 0 1 0 0 1 0 U5 0 
17 MUTHUKUMARSAY 48 0 1 0 0 0 0 0 0 1 0 0 2 0 A 0 
18 JOHN BOSCO 20 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
19 SENTHIL KUMAR 22 0 0 0 0 0 0 1 0 1 0 0 2 1 U6 0 
20 SIDDIQUE 28 0 0 1 0 0 0 0 0 1 0 0 2 0 A 0 
21 MOHAMAD 39 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
22 GOWRISANKER 37 0 0 0 0 0 0 0 0 1 0 1 2 0 A 0 
23 RAMESH 33 0 1 0 0 0 0 0 0 1 0 0 2 0 U7 0 
24 BAKER 44 0 0 0 0 0 0 0 0 1 0 0 1 0 A 0 
25 GANESH 26 0 1 1 0 0 0 0 0 0 0 0 2 0 A 0 
26 SURESH 42 0 1 0 o 0 1 1 0 1 0 1 5 1 A 0 
27 ALAGAPPAN 45 0 1 0 o 0 0 0 0 1 0 0 2 0 U8 0 
28 RAMALINGAM 39 0 0 1 0 0 0 0 0 0 0 0 1 0 A 0 
29 SENTHIL VEL 22 0 0 1 0 0 0 0 0 1 0 0 2 0 U9 0 
30 BANNARI 34 0 1 0 0 0 1 0 1 1 0 0 4 1 A 0 
31 KANNAN 44 0 1 0 0 0 0 0 0 0 0 0 1 0 A 0 
32 THANGARAJ 27 0 1 0 0 0 0 0 0 1 0 0 2 0 A 0
33 DURAIRAJ 32 0 1 0 0 0 0 0 0 1 0 0 2 0 U10 0 
34 ARUMUGAM 23 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
35 KARRUPUSAMY 52 0 1 0 0 0 0 0 0 1 0 0 2 0 A 0 
36 VELUSAMY 38 0 1 1 0 0 1 1 1 1 0 0 6 1 A 1 
37 CHANDRAKALA 23 0 0 0 0 0 0 0 0 1 0 0 1 0 U11 0 
38 RAKIYYAPAN 37 0 1 1 0 0 0 0 0 0 0 0 2 0 A 0 
39 SARAGANAN 39 0 0 0 0 0 0 0 0 1 0 0 1 0 A 0
40 UHAITHULA 39 0 0 0 0 0 0 0 0 1 0 0 1 0 U12 0 
41 VELAVANTHAN 50 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
42 SUBRAMANI 45 0 1 1 0 0 0 0 0 1 0 0 3 0 U13 0 
43 AROKIARAJ 39 0 0 0 0 0 0 1 0 1 0 0 2 1 A 0 
44 SELVAVATHY 41 0 1 1 0 0 0 0 0 1 0 0 3 0 G 0 
45 VIJAY 45 0 1 1 1 0 0 0 0 1 0 0 4 0 A 0 
46 LAKSHMANAN 49 0 0 0 00 0 0 1 0 1 0 0 2 1 A 0
47 SELVAM 45 0 0 0 0 0 0 0 0 1 0 0 1 0 A 0 
48 SASIKUMAR 39 0 1 1 0 0 0 0 0 0 0 0 2 0 A 0 
49 SELVARAJ 51 0 1 1 1 1 0 0 0 1 0 0 5 0 U14 0 
50 GOVINDHARAJ 48 0 1 1 0 0 0 0 0 0 0 0 2 0 0 0 
51 SHANTHI 35 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
52 MOORTHY 48 0 0 0 0 0 0 1 0 1 0 0 2 1 A 0 
53 POONKODI 50 0 0 1 0 0 0 0 0 0 0 0 1 0 G 0 
54 SIVAKUMAR 45 0 1 0 0 0 1 1 1 1 0 1 6 1 U15 0 
55 SIVARAJ 44 0 0 1 0 0 0 0 0 1 0 0 2 0 A 0 
56 ANTONY LEO 40 0 0 1 0 0 0 0 0 0 0 0 1 0 A 0 
57 SARAVANA KU 34 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
58 KATHARARAYAN45 40 0 0 1 0 0 0 0 0 1 0 0 2 0 U16 0 
59 GANESH 
39 0 0 1 0 0 0 0 0 0 0 0 1 1 A 0 
60 GOVINDHARAJ 35 0 1 0 0 0 0 0 0 1 0 0 2 0 A 0 
61 MURAGAN 40 0 1 1 0 0 0 0 0 1 0 0 3 0 AA 0
62 ARUKANIYAMAL 35 0 0 0 0 0 0 0 0 1 0 0 1 0 U17 0 
63 ALLGAPAN 38 0 1 1 0 0 0 0 0 0 0 0 2 0 A 0 
64 KAMARAJ 62 1 0 0 0 0 0 0 0 0 0 0 1 0 A 0 
65 KATTHIRVEL 41 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
66 SIVAKUMAR 51 0 0 1 0 0 0 0 0 0 0 0 1 0 U18 0 
67 SELVARAJ 32 0 1 1 0 0 1 1 0 1 1 0 6 1 A 1 
68 AL BATHA 48 0 0 1 0 0 0 0 0 1 0 0 2 0 A 0 
69 SABUTHEEN 45 0 0 1 0 0 0 0 0 0 0 0 1 0 A 0 
70 MANI 42 0 1 1 0 0 0 0 0 0 0 0 2 0 A 0 
71 RANI 46 0 0 0 0 0 0 1 0 1 0 0 2 1 A 0 
72 MURUGESH 43 0 1 1 0 0 0 0 0 0 0 0 2 0 A 0 
73 SRINIVASAN 26 0 1 1 0 0 0 0 0 1 0 0 3 0 U19 0 
74
SANMUGASUNDRA
M 
34 0 1 0 0 0 0 0 0 1 0 0 2 0 A 0 
75 KUPPURAJ 47 0 0 1 0 0 0 0 0 1 0 0 2 1 A 0 
76 MURUGAIH 21 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
77 BALAMURUGAN 35 0 0 0 0 0 0 1 0 1 0 0 2 1 U20 0 
78 PRABU 23 0 0 1 0 0 0 0 0 1 0 0 2 0 A 0 
79 RAJENDRAN 47 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
80 SELVAKUMAR 54 0 0 0 0 0 0 0 0 1 0 0 1 0 A 0 
81 PARAMASIVA 18 0 0 0 0 0 0 1 0 1 0 0 2 1 U21 0 
82 UDYAKUMAR 36 0 1 1 0 0 1 1 1 1 0 0 6 1 A 0 
83 NIRMALDEVAN 49 0 1 0 0 0 0 0 0 1 0 0 2 0 A 0 
84 CHANDRAN 36 0 0 1 0 0 0 0 0 0 0 0 1 0 A 0 
85 SUBBAIYA 33 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
86 ABDULKATAR 53 0 0 0 0 0 0 1 0 1 0 0 2 1 A 0 
87 YESIN 42 0 0 1 0 0 0 0 0 0 0 0 1 0 A 0 
88 JEGANATHAN 42 0 1 1 0 0 0 0 0 1 0 0 3 0 U22 0 
89 MANIKANDAN 44 0 0 1 0 0 0 0 0 1 0 0 2 0 A 0 
90 ELANGOVAN 48 0 1 0 0 0 0 0 0 1 0 0 2 0 A 0
91 RANJENDRAN 20 0 0 1 0 0 0 0 0 1 0 0 2 0 A 0 
92 KANAGARAJ 45 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
93 NAGARAJAN 72 1 0 1 0 0 0 0 0 0 0 0 2 0 U23 0 
94 RAMESH 40 0 0 1 0 0 0 0 0 0 0 0 1 0 A 0 
95 ARJUNAN 20 0 1 1 0 0 0 1 1 1 0 1 6 1 A 0 
96 KANNAPAN 45 0 1 0 0 0 0 0 0 1 0 0 2 0 A 0 
97 MOHANRAJ 32 0 0 1 0 0 0 0 0 0 0 0 1 0 A 0
98 KANDSSAMY 45 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
99 RANGARAJ 21 0 0 1 0 0 0 0 0 1 0 0 2 0 A 0 
100 NANTHAKUMAR 56 0 1  0 0 0 0 0 1 0 0 2 0 A 0 
101 ROBERT 26 0 1 1 0 0 0 1 1 1 1 0 6 1 A 1 
102 PONNAIYAN 64 1 0 0 0 0 0 0 0 0 0 0 1 0 A 0 
103 GANESAN 32 0 0 1 0 0 0 0 0 1 0 0 2 0 A 0 
104 VAIYAPURI 18 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0
105 BALAKRISHNAN 40 0 1 0 0 0 0 0 0 1 0 0 2 1 A 0 
106 ARIVALAGAN 28 0 1 0 0 0 0 0 0 1 0 0 2 0 A 0 
107 VASANTHAN 32 0 0 1 0 0 0 0 0 1 0 0 2 0 G 0 
108 KANTHARAJ 53 0 0 0 0 0 0 0 0 1 0 0 1 0 A 0 
109 RAVICHANDRAN 37 0 1 0 0 0 0 0 0 1 0 0 2 0 A 0 
110 SARAGAM 24 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
111 VELAVANTHAN 48 0 0 1 0 0 0 0 0 0 0 0 1 0 A 0 
112 SENTHILVEL 47 0 1 1 0 0 0 0 0 1 0 0 3 0 A 0 
113  VINAYAK 31 0 0 1 0 0 0 0 0 1 0 0 2 1 A 1 
114 ULAGANATHAN 35 0 0 0 0 0 0 0 0 1 0 0 1 0 A 0 
115 NARAYANAN 42 0 0 0 1 1 0 0 0 1 0 0 3 0 A 0 
116 SANKARAN 38 0 1 0 0 0 0 0 0 1 0 0 2 1 A 0 
117 JABAKUMAR 45 0 0 1 0 0 0 0 0 1 0 0 2 0 A 0 
G-
H-
I-
J-
Age (yr)  1->55 >70*
WBC  (×1000/mm3)1- 1->16 >18
Glucose (mg/dl) 1->200 >220
AST (IU/L) 1->250 >250
LDH (IU/L) 1->350 >400
Within 48 Hours of Admission
Hematocrit decrease (points) 1->10 >10
BUN increase (mg/dl) 1->5 >2 
Deficit in base(mEq/L) 1->4 >5 
Fluid replaced (L) 1->6 >4 
PaO2 (mm Hg) 1-<60 <60
Calcium (mg/dl) 1-<8 <8 
K- * value for biliary acute pancreatitis 
L- Value for 1 in the master chart is given above other than that value is entered as 0 
M-
ON THE WHOLE MASTER CHART FOR ALL SCORE
Sl.n
o Name Age Sex IP No Ranson
BISA
P CTSI SAP 
Panc 
Nec 
Morta
l Morbi Etiology 
1 VIJAY 37 M 
3320
8 
2 2 2 0 0 0 8 U1 
2 MATHEWS 63 M 
2606
5 
5 4 5 1 1 1 10 A 
3 SIVA 16 M 
2512
5 
2 1 2 0 0 0 10 A 
4 KULANTHAISAMY 43 M 
2106
0 
2 0 4 0 0 0 5 A 
5 GOWRISANKER 23 M 
3178
5 
1 3 1 1 0 1 4 U2 
6 RAMESHKUMAR 25 M 
3115
8 
3 2 4 0 0 0 5 A 
7 HUSSAIN 38 M 
2237
9 
1 2 2 0 0 0 5 A 
8 CHINNAN 53 M 
2087
0 
1 1 1 0 0 0 8 A 
9 KARUPPUSAMY 48 M 
3528
0 
2 2 2 0 0 0 4 U3 
10 PRAKASH 32 M 
3485
2 
5 3 1 1 0 0 13 A 
11 KARUPPUSAMY 44 M 
3313
5 
1 2 4 0 0 1 7 A 
12 KARTHIKAYEN 65 M 
6789
2 
3 2 4 0 0 0 10 U4 
13 MURUGESAN 23 M 
2283
8 
6 4 2 1 1 0 2 A 
14 ARUMUGAM 62 M 2043 2 1 1 0 0 0 3 G
015 SENTHIL KUMAR 65 M 
1316
5 
2 5 4 0 0 0 8 A 
16 KRISHNAN 25 M 9190 1 0 2 0 0 0 5 U5 
17 MUTHUKUMARSAY 48 M 5196 2 2 4 0 0 0 5 A 
18 JOHN BOSCO 20 M 
1942
8 
3 2 2 0 0 0 12 A 
19 SENTHIL KUMAR 22 M 
3586
5 
2 1 7 1 1 0 15 U6 
20 SIDDIQUE 28 M 
5919
0 
2 2 1 0 0 0 3 A 
21 MOHAMAD 39 M 
6000
1 
3 1 1 0 0 0 3 A 
22 GOWRISANKER 37 M 
4989
2 
2 1 5 0 1 0 6 A 
23 RAMESH 33 M 
6001
3 
2 2 2 0 0 0 2 U7 
24 BAKER 44 M 
6062
2 
1 0 2 0 0 0 5 A 
25 GANESH 26 M 
4164
0 
2 3 4 0 0 0 7 A 
26 SURESH 42 M 
3959
7 
5 2 5 1 1 0 6 A 
27 ALAGAPPAN 45 M 
4181
1 
2 2 2 0 0 0 5 U8 
28 RAMALINGAM 39 M 
4383
2 
1 2 2 0 0 0 3 A 
29 SENTHIL VEL 22 M 
1081
3 
2 1 1 0 0 0 4 U9 
30 BANNARI 34 M 1021 4 3 2 1 0 0 10 A 
131 KANNAN 44 M 
1081
3 
1 1 4 0 0 0 3 A 
32 THANGARAJ 27 M 6113 2 0 1 0 0 0 2 A 
33 DURAIRAJ 32 M 1759 2 2 4 0 0 0 5 U10 
34 ARUMUGAM 23 M 3864 3 2 2 0 0 0 4 A 
35 KARRUPUSAMY 52 M 3916 2 1 2 0 0 0 3 A
36 VELUSAMY 38 M 6012 6 4 1 1 0 1 10 A 
37 CHANDRAKALA 23 F 
4239
0 
1 2 5 0 1 0 5 U11 
38 RAKIYYAPAN 37 M 
3320
7 
2 1 2 0 0 0 3 A 
39 SARAGANAN 39 M 
4042
8 
1 2 4 0 0 0 3 A 
40 UHAITHULA 39 M 
4028
5 
1 0 2 0 0 0 2 U12 
41 VELAVANTHAN 50 M 
4129
2 
3 2 4 0 0 0 2 A 
42 SUBRAMANI 45 M 
5880
4 
3 4 5 0 1 0 8 U13 
43 AROKIARAJ 39 M 
3694
0 
2 2 2 1 0 0 3 A 
44 SELVAVATHY 41 F 
5948
6 
3 1 2 0 0 0 6 G 
45 VIJAY 45 M 
6083
4 
4 2 1 0 0 0 5 A 
46 LAKSHMANAN 49 M 
6082
8 
2 3 2 1 0 0 7 A 
47 SELVAM 45 F 
6108
4 
1 1 1 0 0 0 8 A 
48 SASIKUMAR 39 M 
6166
6 
2 2 2 0 0 0 1 A 
49 SELVARAJ 51 M 
6174
6 
5 4 7 0 1 0 6 U14 
50 GOVINDHARAJ 48 M 
6273
3 
2 2 2 0 0 0 5 A 
51 SHANTHI 35 F 
6292
0 
3 1 4 0 0 0 3 A 
52 MOORTHY 48 M 
6140
0 
2 3 2 1 0 0 8 A 
53 POONKODI 50 F 
6332
9 
1 2 4 0 0 0 7 G 
54 SIVAKUMAR 45 M 
6352
3 
6 1 1 1 0 0 2 U15 
55 SIVARAJ 44 M 
6389
2 
2 2 2 0 0 0 4 A 
56 ANTONY LEO 40 M 
7386
6 
1 1 1 0 0 0 2 A 
57 SARAVANA KU 34 M 
6704
3 
3 2 4 0 0 0 8 A 
58 KATHARARAYAN45 40 M 
6482
7 
2 0 2 0 0 0 3 U16 
59 GANESH 39 M 
5983
4 
1 3 2 1 0 0 8 A 
60 GOVINDHARAJ 35 M 
5906
0 
2 1 5 0 0 0 9 A 
61 MURAGAN 40 M 
7079
8 
3 0 1 0 0 0 2 AA 
62 ARUKANIYAMAL 35 F 
5815
7 
1 1 4 0 1 0 10 U17 
63 ALLGAPAN 38 M 
6637
3 
2 2 2 0 0 0 7 A 
64 KAMARAJ 62 M 
6507
8 
1 1 1 0 0 0 4 A 
65 KATTHIRVEL 41 M 
6507
8 
3 2 2 0 0 0 7 A 
66 SIVAKUMAR 51 M 
6000
8 
1 0 2 0 0 0 6 U18 
67 SELVARAJ 32 M 
5875
3 
6 4 1 1 0 1 5 A 
68 AL BATHA 48 M 
7145
4 
2 1 2 0 0 0 8 A 
69 SABUTHEEN 45 M 
7134
1 
1 2 5 0 1 0 3 A 
70 MANI 42 M 
5391
2 
2 1 1 0 0 0 6 A 
71 RANI 46 F 
1600
7 
2 2 5 1 1 0 7 A 
72 MURUGESH 43 M 
4888
4 
2 0 2 0 0 0 8 A 
73 SRINIVASAN 26 M 
4761
2 
3 0 2 0 0 0 4 U19 
74 SANMUGASUNDRAM 34 M 
4625
0 
2 1 2 0 0 0 8 A 
75 KUPPURAJ 47 M 
4412
2 
2 4 5 1 1 0 8 A 
76 MURUGAIH 21 M 
6941
6 
3 2 1 0 0 0 12 A 
77 BALAMURUGAN 35 M 
5052
2 
2 1 2 1 0 0 2 U20 
78 PRABU 23 M 
6670
6 
2 2 4 0 0 0 4 A 
79 RAJENDRAN 47 M 
5211
1 
3 3 1 0 0 0 5 A 
80 SELVAKUMAR 54 M 
4891
4 
1 0 4 0 0 0 4 A 
81 PARAMASIVA 18 M 
4732
2 
2 2 2 1 0 0 3 U21 
82 UDYAKUMAR 36 M 
7147
0 
6 2 2 1 0 0 5 A 
83 NIRMALDEVAN 49 M 
3378
7 
2 0 1 0 0 0 8 A 
84 CHANDRAN 36 M 
3380
0 
1 2 2 0 0 0 6 A 
85 SUBBAIYA 33 M 
3691
6 
3 1 5 0 1 0 15 A 
86 ABDULKATAR 53 M 
3834
2 
2 3 4 1 0 0 2 A 
87 YESIN 42 M 
3845
9 
1 2 1 0 0 0 6 A 
88 JEGANATHAN 42 M 
4025
2 
3 1 4 0 0 0 3 U22 
89 MANIKANDAN 44 M 
4136
0 
2 0 2 0 0 0 5 A 
90 ELANGOVAN 48 M 
4279
9 
2 2 1 0 0 0 10 A 
91 RANJENDRAN 20 M 
4507
5 
2 0 2 0 0 0 5 A 
92 KANAGARAJ 45 M 
5293
0 
3 1 4 0 0 0 4 A 
93 NAGARAJAN 72 M 
6036
1 
2 2 2 0 0 0 5 U23 
94 RAMESH 40 M 
5893
4 
1 1 1 0 0 0 8 A 
95 ARJUNAN 20 M 
7198
7 
6 4 4 1 0 0 13 A 
96 KANNAPAN 45 M 
7081
2 
2 2 2 0 0 0 12 A 
97 MOHANRAJ 32 M 
7081
2 
1 0 1 0 0 0 6 A 
98 KANDSSAMY 45 M 
6175
4 
3 2 5 0 1 0 6 A 
99 RANGARAJ 21 M 
5429
8 
2 0 2 0 0 0 5 A 
100 NANTHAKUMAR 56 M 
3952
4 
2 2 2 0 0 0 5 A 
101 ROBERT 26 M 
1755
2 
6 2 5 1 1 1 5 A 
102 PONNAIYAN 64 M 
1679
7 
1 1 1 0 0 0 2 A 
103 GANESAN 32 M 
1252
3 
2 4 4 0 0 0 5 A 
104 VAIYAPURI 18 M 
1446
0 
3 2 2 0 0 0 5 A 
105 BALAKRISHNAN 40 M 
1429
4 
2 1 2 1 0 0 15 A 
106 ARIVALAGAN 28 M 
1433
5 
2 2 1 0 0 0 10 A 
107 VASANTHAN 32 M 
1307
7 
2 0 4 0 0 0 6 G 
108 KANTHARAJ 53 M 
1159
5 
1 2 2 0 0 0 15 A 
109 RAVICHANDRAN 37 M 
6597
6 
2 2 2 0 0 0 10 A 
110 SARAGAM 24 M 
6843
5 
3 2 4 0 0 0 6 A 
111 VELAVANTHAN 48 M 
6355
5 
1 1 2 0 0 0 20 A 
112 SENTHILVEL 47 M 
6364
7 
3 2 1 0 0 0 11 A 
113  VINAYAK 31 M 
4883
7 
2 4 2 1 1 1 1 A 
114 ULAGANATHAN 35 M 
4025
2 
1 2 1 0 0 0 13 A 
115 NARAYANAN 42 M 
3848
9 
3 1 4 0 0 0 7 A 
116 SANKARAN 38 M 
4840
1 
2 2 2 1 0 0 8 A 
117 JABAKUMAR 45 M 
4568
4 
2 0 1 0 0 0 4 A 
A – Alcohol 
U – Unknown 
G- Galbadder 
PATIENT CONSENT FORM 
STUDY: A COMPARATIVE STUDY OF VARIOUS PROGNOSTICS SCORING SYSTEM (RANSON, BISAP, CTSI) 
IN ACUTE PANCREATITIS 
 This study has been explained to me in my own language and I understood the following 
1. What the study involves 
2. That the refusal to participate will not affect my treatment in any way 
3.  That I may withdraw to take part in this study 
Signature of the patient: 
Full name of the patient: 
Address: 
Date: 
Witness: (should be a person not connected with the study) 
 I have been present while the procedure to be performed has been explained to the patient and I have witnessed 
his/her consent to take part. 
Signature of the witness: 
Full name of the witness: 
Address: 
Date:
